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Adipose-resident regulatory T cells are protective against local inflammation, and 
are believed to play a critical role in preserving insulin sensitivity and glucose tolerance.  
Although their basic markers and roles have been studied, less is known about the 
transcriptional machinery regulating their differentiation and function. 
B lymphocyte-induced maturation protein-1 (Blimp-1) is a transcriptional regulator 
known to be involved in development, polarization, and maintenance of various immune 
cells including CD4+ T cells.  Using Blimp-1 reporter mice, we discovered that Blimp-1 is 
constitutively expressed in a subset of visceral adipose tissue (VAT) Tregs, and that 
Blimp-1+ VAT Tregs are phenotypically distinct from their Blimp-1- counterparts.  We also 
found that Treg-specific Blimp-1 deletion led to reduced ST2+ KLRG1+, IL-10-producing 
VAT and inguinal adipose tissue (IAT) Tregs.  Surprisingly, during diet-induced obesity, 
Blimp-1 Treg deficient mice gained less weight, had reduced body fat percentage, and 
exhibited improved insulin sensitivity compared to wild-type mice.  Furthermore, this was 
accompanied by white adipocyte beiging.  It has previously been shown that IL-10 can 
directly induce thermogenesis.  Therefore, we repeated these experiments utilizing mice 
with Treg-specific deletion of IL-10 and found that they phenocopied the Blimp-1 Treg 
deficient mice.  In summary, these findings reveal that Treg-adipocyte cross-talk can 
occur via a Blimp-1/IL-10 axis, and that the absence of Blimp-1+ Tregs increases white 
adipose tissue beiging and is metabolically protective against diet-induced obesity. 
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1.0 Introduction 
1.1 Epidemiology and etiology of obesity 
Obesity is a growing worldwide epidemic.  Since 1975, the number of people with 
obesity has tripled globally, with more people now residing in a country where annual 
cases of obesity-related deaths exceed those due to malnutrition1.  In the United States, 
obesity rates have continuously risen over the last 20 years2, 3.  In 2017-2018, 70% of 
adults and 35% of children and adolescents between the ages of 2-19 were overweight 
or obese2, 4.  This has translated to staggering economic costs.  A recent analysis of the 
obesity-related medical expenditures in the United States estimated 260 billion dollars 
were spent in 2016 alone5.  This did not take into account indirect costs such as loss of 
workplace productivity or burden to caregivers6, 7.  
Obesity is a serious medical condition because it is tied to numerous co-morbidities 
including Type 2 diabetes, cardiovascular disease, fatty liver disease, respiratory 
challenges, cancer and depression8, 9.  Furthermore, the current SARS-CoV-2 global 
pandemic has once again drawn attention to the dangers of obesity, as individuals with 
this condition have suffered higher rates of hospitalization and case fatality10.   
Obesity is clinically defined as having a body mass index of 30kg/m2.  Fat 
deposition can occur at various sites within the body, but an excess of visceral fat around 
the abdominal organs makes individuals especially prone to developing comorbidities8.  
Although there is a tendency to attribute obesity to poor diet and a sedentary lifestyle, it 
is actually a multi-factorial disease with many biological, genetic, social and behavioral 
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contributors.  These include but are not limited to: genetic predisposition, status of the gut 
microbiota, poor sleep quality, stress, changes in metabolism due to prescription 
medications or age, and socioeconomic factors8. 
Recently, researchers have found that an individual’s immune system also plays 
an important role in obesity as well.  In lean, healthy individuals, the adipose is populated 
by anti-inflammatory immune cells11.  However, during obesity, the presence of pro-
inflammatory immune cells has been linked to disruptions in insulin signaling and glucose 
tolerance11.  Although weight loss is promoted as a means of addressing these problems, 
it is clear from the epidemiological data that this so far has not been a viable solution for 
most people.  Therefore, immunological interventions have recently garnered interest as 
a possible alternative to combating obesity12. 
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Figure 1. Adipose-resident immune cells in lean and obese adipose tissue. 
In lean mice, the white adipose tissue is populated primarily by anti-inflammatory immune cells that secrete 
cytokines that help maintain insulin sensitivity and glucose tolerance.  However, during obesity, there is a 
higher frequency of pro-inflammatory immune cells that release cytokines that exacerbate insulin resistance 
and glucose intolerance.  In addition, adipocytes themselves can secrete adipokines that affect metabolic 
homeostasis. 
1.2 Immunopathology of obesity 
Adipose tissue has traditionally been viewed as energy repositories consisting of 
lipid-storing adipocytes.  However, within the past decade, a growing body of evidence 
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has made it clear that the adipose is also an endocrine organ that plays a critical role in 
maintaining systemic metabolism.  This is made possible by the fact that adipose tissue-
resident immune cells as well as adipocytes themselves secrete cytokines and adipokines 
that allow cross-talk amongst each other as well as with the rest of the endocrine system.  
In this section, we will start by covering how obesity leads to adipose tissue remodeling 
and changes in the immune cell compartment, and then proceed to explore how these 
events affects 2 key processes that are critical for maintaining metabolic homeostasis- 
thermogenesis and insulin sensitivity.  
1.2.1 Adipose tissue immune homeostasis is modulated by adipocyte 
morphology, the adipokine milieu and oxygen availability. 
Adipose tissue can be categorized into two forms- brown adipose tissue (BAT) and 
white adipose tissue (WAT).  Brown adipose tissue contains adipocytes with multiple 
small lipid droplets and abundant amounts of mitochondria that aid in energy dissipation 
through thermogenesis (i.e. heat production) via uncoupling protein 1 (UCP1)11, 13.  White 
adipose tissue can be further subcategorized into subcutaneous adipose tissue (scAT) 
and visceral adipose tissue (VAT).  VAT is the fat surrounding intra-abdominal organs, 
whereas the scAT is the fat which exists right underneath the skin14.  In addition to scAT 
and VAT, WAT can also be found in more limited quantities in the bone marrow, 
perivascular, epicardial and mediastinal retro-orbital space9.  White adipocytes are 
usually characterized by a single large triglyceride-containing lipid droplet and have fewer, 
variable amounts of mitochondria13.  Initially, the WAT’s sole purpose was thought to be 
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lipid storage8.  However, it is now clear that the scAT also contains “beige” adipocytes 
that possess thermogenic potential similar to that of brown adipocytes8. 
Whether or not adipose tissue homeostasis is maintained relies on the balance 
between tissue-resident anti-inflammatory immune cells (e.g. alternatively activated M2 
macrophages, regulatory T cells (Treg), type 2 innate lymphoid cells (ILC2), eosinophils 
and T helper 2 cells (Th2)) and pro-inflammatory immune cells (e.g. classical M1 
macrophages, CD8 T cells, T helper 1 cells (Th1) and T helper 17 cells (Th17)), as well 
as how these immune cells interact with adipocytes11.  In lean, healthy adipose tissue, 
white and brown adipocytes produce adiponectin15, 16.  This adipokine induces antigen-
presenting cells to secrete anti-inflammatory cytokines such as IL-10, IL-1RA, ARG1, 
MGL1, and Chi3l3 while also inhibiting their ability to release pro-inflammatory cytokines 
such as IFNg, TNFa, CCL2, IL-6, and iNOS17, 18, 19, 20.  In addition to adipocytes, certain 
subclasses of mesenchymal stromal cells secrete IL-33, a cytokine that supports 
maintenance of Tregs and ILC2 cells11.  ILC2-derived cytokines, such as IL-5 and IL-13, 
support the maintenance of eosinophils, which through secretion of IL-4 can promote M2 
macrophage polarization21, 22.  Furthermore, adipose Tregs and a NK1.1NEG subclass of 
invariant natural killer T cells (iNKT) can secrete IL-1023, 24 10, which can further promote 
M2 polarization, and also prohibit inflammatory signaling in adipocytes25. 
However, during obesity, white adipocytes undergo hyperplasia (i.e. increased cell 
proliferation therefore resulting in more adipocytes for lipid storage) and hypertrophy (i.e. 
increased lipid storage per individual cell) to accommodate excess fat8.   When the latter 
occurs, adipocytes that become too large can burst leading to the recruitment of 
macrophages whose job is to clear cellular debris26-28.  However, the free fatty acids 
 6 
released from ruptured adipocytes also induces macrophages to produce TNFa which in 
turn acts back on intact adipocytes to induce expression of CCL2, a chemoattractant for 
myeloid and lymphoid cells29.   
This immune cell infiltration turns inflammatory in nature due to alterations in the 
adipokine milieu during excessive fat gain.  During obesity, a rise in circulating leptin 
exacerbates inflammation by promoting recruitment, differentiation, maintenance and 
function of pro-inflammatory immune cells such as macrophages, neutrophils, dendritic 
cells, granulocytes, NK cells, Th1 and Th17 cells while inhibiting differentiation, 
maintenance and function of anti-inflammatory immune cells such as Th2 and Treg 
cells30.  In addition, obesity results in increased secretion of soluble ST2 (sST2) adipokine 
in the VAT.  sST2 is a decoy receptor for IL-33.  In high fat diet (HFD)-fed mice, the 
presence of sST2 leads to decreased frequency of Tregs and ILC2s31. 
Besides changes in adipokines, hypoxia may also worsen inflammation in 
expanding adipose tissue32, 33.  Blood vessels deliver oxygen to the adipose tissue.  In 
one study, HFD mice underwent adipose tissue-specific deletion of vascular endothelial 
growth factor (VEGF), a growth factor necessary for angiogenesis and delivery of oxygen 
to cells.  This deletion resulted in adipocyte apoptosis, macrophage infiltration, and an 
increase in inflammatory PAI-1, TNFa and CCL2, and a decrease in anti-inflammatory 
adiponectin within the WAT34.  Although these findings don’t rule out the possibility that 
these results were attributable to other factors such as decreased macronutrient delivery, 
in vitro experiments with human adipocytes and immune cells have demonstrated that 
hypoxia can directly increase inflammatory IL-6, leptin, PAI1, CCL2, and TNFa while 
reducing anti-inflammatory adiponectin and IL-1035. 
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White and brown adipocytes can have differential effects on immune cells.  For 
example, BAT secretes lower levels of IL-6 compared to WAT36.  When macrophage cell 
lines were co-cultured with differentiated white adipocytes, macrophages exhibited a pro-
inflammatory gene signature and more IL-6 was detected in the media compared to 
monocultured macrophages36.  However, this did not occur when macrophages were co-
cultured with differentiated brown adipocytes36.  The anti-inflammatory nature of BAT has 
also been demonstrated in transplant studies.  In one study by Shankar et al. (2018), 
intrascapular BAT transplantation into HFD mice led to the VAT having decreased 
frequency of M1 macrophages and CD8 T cells, and increased frequency of Tregs37.  In 
addition, when mice underwent BAT transplants, the VAT presented with decreased 
expression of pro-inflammatory cytokines Mcp1, Il6, Tnfa and Jnk1, while expression of 
anti-inflammatory cytokines Il1b, Arg1, Chi3l3 and Il10 simultaneously increased37. 
1.2.2 A global overview of how careful coordination between adipose depots and 
other endocrine organs maintains insulin sensitivity and glucose tolerance. 
The body requires nutrients to meet its basal as well as active energy needs.  The 
liver plays a major role in stabilizing glucose levels.  It is the primary organ responsible 
for endogenous glucose production when the body is fasting38.   Upon meal consumption, 
glucose triggers the pancreatic ß-cells to secrete insulin into the bloodstream39.  
Circulating insulin binds to its receptors on adipose, liver and muscle cells to upregulate 
glucose, fatty acid, and protein transporters nutrients can be shuttled from the blood into 
these organs39.  In addition, insulin signaling halts gluconeogenesis within the liver38. 
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However, during obesity, cells become insulin resistant (i.e. they stop responding 
to insulin), and thus lipids are not removed from the bloodstream.  Reduced insulin 
sensitivity also increases hormone-sensitive lipase (HSL) activity within hypertrophic 
adipocytes causing them to undergo increased lipolysis40.  Release of free fatty acids 
leads to recruitment of macrophages that secrete cytokines that further accelerate 
lipolysis39.  Overall, this results in increased circulating free fatty acids.  Initially, the 
pancreas synthesizes additional insulin as a compensatory mechanism resulting in 
hyperinsulinemia41.  However, over time, prolonged exposure to high fatty acid levels 
induces cellular stress responses in the pancreas that cause b-cell dysfunction and 
apoptosis resulting in Type 2 Diabetes, a condition in which pancreatic insulin production 
is partially or completely abolished41. 
Besides damaging pancreatic b-cells, lipids also have a harmful effect on the liver.  
Livers import fatty acids to generate ATP40.  However, any excess fatty acids are stored 
as triglycerides40.  In addition, the liver imports glucose which can be utilized in de novo 
triglyceride synthesis40.  Excess triglycerides accumulation leads to hepatic steatosis (i.e. 
fatty liver disease), which has been linked to metabolic dysfunction42.  During the early 
stages of obesity, hepatic steatosis may correlate positively with hyperinsulinemia, most 
likely due to the liver’s diminished capacity to clear plasma insulin38.  In addition, hepatic 
steatosis has been associated with continued gluconeogenesis even in the fed state, 
which likely worsens hyperglycemia39. 
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1.2.3 BAT, scAT beige adipocytes, and anti-inflammatory immune cells promote 
thermogenesis and is protective against insulin resistance. 
BAT and scAT beige adipocytes play a critical role in preserving metabolic 
homeostasis.  In human adults, greater BAT mass is negatively correlated with BMI and 
fasting glucose43.  In addition, BAT transplantation into both lean and obese mice results 
in improved insulin sensitivity and glucose tolerance44.  Furthermore, multiple studies 
have demonstrated that preservation of beige adipocytes curbs diet-induced obesity 
(DIO) in mice45-48.  The protective capacity of brown and beige adipocytes appears to be 
in part due to their ability to carry out thermogenesis to maintain core body temperature.  
Once activated by cold exposure, exercise, thyroid hormones, ß3-adrenergic agonist, or 
diets rich in protein, polyunsaturated fatty acids and capsinoids, BAT and beige 
adipocytes tap into their intracellular triglyceride stores to free fatty acids that are then 
utilized in ß-oxidation for ATP and heat generation9.  As lipids are utilized, the BAT imports 
exogenous fatty acids and glucose to synthesize triglycerides to replace the ones that 
were recently utilized9.  This process removes nutrients from the bloodstream, and thus 
helps maintain normoglycemia, normolipidemia and insulin sensitivity.  
Adipose-resident immune cells are believed to help regulate thermogenesis.  The 
BAT is more resistant to inflammation compared to scAT or VAT49, 50.  Unlike lean scAT 
which contains a notable amount of immune cells, CD45+ leukocytes make up less than 
5% of live cells within the BAT of 8wk old mice51.  In addition, in HFD-fed mice, marked 
BAT immune cell filtration does not occur until after 6 months on HFD49, 50.  One proposed 
reason for this is that brown adipocytes utilize a large amount of fatty acids and glucose 
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to generate heat,  and thus the supply of nutrients available to support immune cell 
maintenance and function is limited52. 
Of the known BAT immune cells, macrophages are the most well-characterized.  
BAT macrophage frequency and phenotype can be age and diet-dependent.  For 
example, Peterson et al. (2017) found that F4/80+ total macrophages comprise about 
30% of BAT leukocytes after 8wks on low fat diet, but only 20% of BAT leukocytes after 
8wks on HFD51.  However, in one study by Sakamoto et al. (2016), the relative expression 
of F4/80 and Tnfa mRNA doubled in the BAT after 16wks on HFD compared to 16wks on 
normal diet53.  Interestingly, a study by Wolf et al. (2017) highlighted how BAT 
macrophages may cross-talk with BAT-innervating neurons to regulate metabolic 
homeostasis.  They found that CX3CR1+ macrophage-specific Mecp2 deletion led to 
decreased sympathetic innervation of the BAT, homeostatic thermogenesis and energy 
expenditure in 6-month-old mice54.  Furthermore, a subset of BAT macrophages were in 
direct contact with BAT neurons, and Mecp2 deletion resulted in disruption of the plexin-
semaforin signaling axis that modulates norepinephrine activated thermogenesis54.  
Besides macrophages, other types of immune cells such as Siglecf+ eosinophils, ILC2s 
and mast cells have been found in the BAT, however whether or not they play a direct 
role in thermogenesis remains to be determined51, 55, 56. 
In contrast to the BAT, the role of WAT macrophages, eosinophils, ILC2s and mast 
cells in regulating thermogenesis has been better described.  During cold-induced 
thermogenesis, scAT adipocytes secrete adiponectin which can directly and selectively 
promote the proliferation of M2 macrophages over M1 macrophages57.  In cold-
challenged mice, deletion of mononuclear phagocytes by clodronate liposomes leads to 
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reduced scAT macrophages and decreased Ucp-1 and Cidea suggesting M2 
macrophages play a role in adipocyte beiging during adaptive thermogenesis57.  M2 
macrophages are supported by eosinophils.  Eosinophils are the primary IL-4 producers 
in the scAT, and loss of IL-4 producing eosinophils, selective deletion of Il4r in myeloid 
cells, or disruption of IL-4/13 or STAT6 signaling leads to fewer M2 macrophages, and 
reduced scAT beige adipocyte biogenesis and thermogenesis58, 59 60.  Besides 
eosinophils, ILC2s also play a major role in promoting beiging.  ILC2-derived IL-13 and 
IL-5 support maintenance of VAT M2 macrophages and eosinophils21.  Furthermore, in 
the scAT of thermoneutral mice, IL-33 activated ILC2s secrete IL-13, which works 
synergistically with eosinophil-derived IL-4 to induce beiging in PDGFRa+ adipocyte 
precursor cells60.  Interestingly, ILC2s can also secrete methionine-enkephalin (MetEnk) 
to directly promote scAT beiging independently of macrophages, eosinophils or an 
adaptive immune response61. 
Besides ILC2s, eosinophils and macrophages, mast cells may also play a role in 
scAT beiging although the trends in humans and mice differ.  Cold-shocked human mast 
cells can secrete histamine and IL-4, and each of these factors individually or in 
combination can induce Ucp1 expression in differentiated adipocytes in vitro62.  However, 
in mice, mast-cell derived serotonin has been found to suppress norepinephrine-induced 
scAT beiging63.  In addition, in HFD mice, ablation of mast cell serotonin synthesis led to 
increased scAT beiging, and curtailed weight gain and insulin resistance64. 
In addition to ILC2s, eosinophils, macrophages and mast cells, Tregs have also 
been described for their role in maintaining metabolic homeostasis.  These cells are the 
focus of this project and will be discussed in greater detail in the following chapters. 
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Besides thermogenesis-driven insulin sensitivity preservation, batokines (i.e. BAT-
secreted cytokines) such as neuregulin 4 (NRG4), fibroblast growth factor 21 (FGF21), 
and IL-6 may also help maintain metabolic homeostasis15.  For example, NRG4 is highly 
enriched in BAT compared to other organs, and Nrg4 deficient HFD mice exhibit 
worsened hepatic steatosis as a result of increased de novo lipogenesis in hepatocytes65.  
In addition, it has previously been shown that Fgf21 null mice have reduced lipid and 
glucose metabolism in the liver during the fasted state66, 67.  Finally, IL-6 is known to 
perform multiple metabolically-related functions such as regulating insulin secretion by 
the pancreas as well as controlling insulin clearance from the liver and skeletal muscle68-
70. 
1.2.4 Obesity-driven changes in the WAT immune cell compartment suppress 
thermogenesis. 
During obesity, scAT macrophage frequency correlates positively with adipocyte 
hypertrophy in mice, and BMI in humans71.  This is detrimental because during DIO, direct 
adhesion of macrophages to adipocytes through a4-integrin/VECAM-1 interaction can 
suppress UCP-172.  In addition, macrophages from obese tissue can secrete IL-1ß and 
TNFa, which dampen thermogenesis53, 73, 74.  In contrast to macrophages, pro-
thermogenic ILC2s are decreased in the scAT of obese mice compared to that of lean 
mice56. 
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1.2.5 Additional considerations for adipose immunobiology and its role in 
metabolic homeostasis. 
Although at first glance it may appear that lean adipose tissue is associated with 
anti-inflammatory immune cells, while obese adipose tissue is tied to pro-inflammatory 
immune cells, it is important to note that the immunopathology of obesity is much more 
nuanced than this simplified description.  For example, adipose-resident immune cells 
display extreme heterogeneity.  In one study, single cell RNA-seq uncovered 7 distinct 
macrophage subpopulations in the VAT, and all of them changed their transcriptional 
signatures in response to diet alteration75.  In addition, adipose immune cells can be 
shaped by metabolic reprogramming of cells in response to nutrient availability76.  
Furthermore, adipocytes and immune cells can be influenced by aging and sex 
hormones77.  Finally, a recent study found that the adipose tissue can possess 
“obesogenic memory”, a condition in which HFD-induced inflammation is irreversible even 
after mice are placed back on standard chow and lose weight78.  Hence, any findings 
within the adipose tissue must be examined carefully and understood that they are 
context-dependent. 
1.3 The role of Tregs in adipose tissue and systemic metabolism 
Many types of immune cells including macrophages, eosinophils, ILC2s and mast 
cells regulate adipose tissue homeostasis and systemic metabolism.  However, more 
recently, regulatory T cells have caught the attention of adipose immunologists as an 
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abundance of emerging literature suggest that these cells play a critical role in metabolic 
homeostasis.  Adipose resident regulatory T cells (aTregs) are present within both white 
and brown adipose tissue, and are shaped by multiple factors including diet, age and 
sex11, 79-82 80.  Unless otherwise noted, this section will focus on Tregs from male C57BL/6 
mice only, as they are the primary mouse model currently being used in adipose 
immunobiology studies, and because these were the animals that were utilized in this 
project.  We will begin by first reviewing the role of Tregs in adipose tissue immune 
homeostasis, then describe how they regulate insulin sensitivity and thermogenesis. 
1.3.1 The role of Tregs in adipose tissue immune homeostasis. 
Tregs play an important role in maintenance of adipose tissue immune 
homeostasis, and loss of Tregs results in inflammation.  In lean, 10wk old mice, selective 
deletion of Tregs by diphtheria toxin led to higher levels of pro-inflammatory mediators 
Tnfa, Il6, Rantes, and Saa3 in the VAT23.  The exact mechanism by which Tregs suppress 
adipose inflammation is undefined, however we can propose at least two ways in which 
this may occur.  One possibility is that Tregs act directly on adipocytes.  aTregs can 
secrete IL-1023 10, and in vitro studies have found that IL-10 can directly suppress LPS-
induced IL-6 production by 3T3-L1 adipocytes83.  The second possibility is that aTregs 
favor anti-inflammatory M2 macrophage polarization.  In the VAT, macrophages are the 
primary cells capable of MHCII mediated interactions with T cells in both lean and obese 
mice84.  Loss of PPAR+ Tregs in lean mice has been shown to increase pro-inflammatory 
CD11b+ CD11c+ F4/80+ macrophages and CD11b+ Ly6chi monocytes in the VAT85.  
Furthermore, it has previously been shown that Tregs can promote M2 macrophages 
 15 
during both human and mouse in vitro experiments, and in mouse models of acute lung 
injury86-88. 
1.3.2 The role of Tregs in insulin sensitivity and thermogenesis. 
Besides suppressing inflammation, Tregs also play a critical role in controlling 
insulin sensitivity and glucose tolerance89-91.  For example, in lean, 10wk old mice, 
selective deletion of Tregs by diphtheria toxin led to increased fasting insulin23.  In HFD-
fed mice, VAT Treg maintenance is reliant on IL-33/ST2 signaling, and disruption of this 
pathway leads to insulin resistance and glucose intolerance31, 91, 92.  Interestingly, fat 
Tregs appear to exacerbate age-associated insulin resistance in mice, as loss of PPARg+ 
Tregs leads to reduced fasting insulin and glucose, and improved sensitivity during 
glucose tolerance and insulin tolerance tests93. 
In addition to regulating insulin, recent studies in nontraditional mouse models (i.e. 
not male C57BL/6 mice) have uncovered a potential role for Tregs in regulating 
thermogenesis.  In one study, Medrikova et al. (2015) utilized female C57BL/6 mice and 
found that BAT Tregs possess a temperature-sensitive gene signature that differs from 
splenic or VAT Tregs82.  When these mice underwent Treg depletion and were cold-
challenged, the Treg-deficient mice exhibited decreased oxygen consumption, body heat 
and BAT thermogenic gene expression82.  In a breakthrough study by Kalin et al. (2017), 
male BALB/c mice were either cold challenged, underwent ß3-adrenergic stimulation or 
fed high sugar high fat (HSHF) diet to investigate the capacity of WAT and BAT Tregs to 
be induced from naïve CD4 T cells, and to see how this potentially affected 
thermogenesis94.  In response to short-term cold acclimation, BAT, scAT and VAT Tregs 
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were all inducible from naïve CD4 T cells94.  In response to ß3-adrenergic stimulation, 
BAT and scAT Treg induction potential was greater than VAT Treg induction potential 
from naïve CD4 T cells94.  Next, 6wk old C57BL/6 or 8wk old BALB/c mice were placed 
on high-fat/high-sugar (HFHS) diet for 2 weeks94.  The result was increased BAT Tregs 
and decreased VAT Tregs in both C57CL/6 and BALB/c mice compared to standard chow 
control mice94.  In addition, in HFHS BALB/c mice, scAT Tregs were reduced in 
comparison to standard chow control mice94.  During longer periods on HFHS diet (8wks 
for C57BL/6 mice, 16wks for BALB/c mice), both strains exhibited reduced frequency of 
VAT Tregs, but not scAT or BAT Tregs94.  Treg depletion in BALB/c mice followed by ß-
adrenergic stimulation or short-term HFHS diet led to decreased thermogenesis, lipolysis 
and ß-oxidation compared to mice that had their Tregs intact94.  Gain-of-function 
experiments with in vivo Treg transfer or in situ expansion of Tregs via subcutaneous IL-
2 injection led to increased thermogenesis, lipolysis and ß-oxidation in the BAT and 
scAT94.  In the end, they found that ß-adrenergic signaling induced BAT naïve CD4 T 
cells into becoming Treg through a STAT6/PTEN axis, and that these BAT Tregs in turn 
enhanced thermogenesis, ß-oxidation, lipolysis and adipocyte differentiation94.  Similar 
observations were also made to smaller degrees in scAT and VAT94.  To note, these 
BALB/c mice had higher frequencies of scAT and BAT Tregs than VAT Tregs, which is 
the opposite of what is found in C57BL/6 mice94.  However, in support of the findings in 
BALB/c mice, studies using humanized mice also found that ß-adrenergic signaling 
enhanced the induction potential of VAT Tregs from naïve CD4 T cells in vitro, and led to 
increased VAT Treg frequency and thermogenesis in vivo95. 
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1.4 Adipose tissue-resident Treg development, differentiation and maintenance 
1.4.1 VAT Treg development, differentiation and maintenance 
In lean mice, VAT Tregs reach a peak frequency of 40% of total CD4 T cells at 
~25wks of age, before falling to about 10% by 40wks of age79, 96.  In contrast, VAT Tregs 
comprise only about 10% of total CD4 T cells in mice that received HFD for 8-29wks23, 79.  
The transcriptional signature of VAT Tregs from lean mice differs from that of VAT Tregs 
of obese mice, or Tregs found in other peripheral tissues and secondary lymphoid 
organs79, 97.  Canonical markers of lean VAT Tregs include: FOXP3, GATA3, PPAR, 
KLRG1, CCR2, ST2, NRP1 and IL-1091, 96, 98. 
VAT Treg maintenance and differentiation is driven by TCR stimulation, iNKT-
derived IL-299, and PDGFRa+ Sca-1+ mesenchymal stromal cell-derived IL-3319.  In VAT 
Tregs, TCR signaling in the presence of IL-2 induces the transcription factors BATF and 
IRF4 to directly bind Pparg and Il1rl1 (the gene encoding ST2) to upregulate their 
expression92, 100.  TCR signaling in the presence of IL-2 is sufficient to induce ST2 
expression, however the addition of IL-33 further promotes its expression92.  IL-33/ST2 
signaling in VAT Tregs requires the adaptor protein MyD8892, and is especially important 
for VAT Treg maintenance91, 92.  Disruption of IL-33/ST2 signaling by soluble ST2 (sST2), 
an alternative isoform which behaves as a IL-33 decoy receptor, leads to decreased VAT 
Treg frequency31.  ST2+ Tregs are reduced in obese adipose tissue compared to lean 
adipose tissue, but administration of IL-33 can recover these cells91.  While ST2 plays an 
important role in maintenance, cooperation between the transcription factors PPAR and 
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Foxp3 drives the VAT Treg signature, especially the genes involved in lipid metabolism 
that are distinctly upregulated in VAT Tregs compared to muscle or colon Tregs85, 97.   
Two landmark studies by Kolodin et al. (2015) and Li et al. (2018) have provided 
key insight into how the pathways above are spatially and temporally organized to dictate 
VAT Treg development, differentiation and maintenance.  In Kolodin’s study, it was 
determined that VAT Tregs are likely thymically-derived, as they found little evidence of 
VAT Tregs being acquired from circulating peripheral Tregs or from conversion of VAT 
Foxp3- CD4+ T effector cells into VAT Tregs96.  Tregs seeded the VAT prior to 3wks of 
age, as mice that underwent thymectomies after this point exhibited no differences in VAT 
Treg frequency96.  Within lean 15-week-old mice, there was a higher frequency of VAT 
Tregs compared to VAT CD4 T effector or splenic Tregs that was attributable to slower 
cellular turnover of VAT Tregs relative to the other two populations96.  At 25 weeks of age, 
VAT Tregs exhibited substantial clonal expansion compared to VAT CD4 T effector cells 
or lymph node Tregs96.  In addition, total MHCII-deficient mice had fewer VAT Tregs 
indicating that antigen presentation was important for either thymic selection of VAT-
destined Tregs, and/or for maintenance of VAT Tregs once they were within the tissue96.  
Furthermore, they identified these MHCII+ cells as being macrophages and dendritic 
cells96.  Finally, they demonstrated utilizing total ST2-deficient mice as well as through 
IL33 injections that IL33-ST2 signaling played a significant role in VAT Treg expansion 
independent of TCR-MHCII interactions96.  
In a follow-up study by the same lab, Li et al. (2018) utilized VAT Treg TCR 
transgenic, PPAR reporter or VAT Treg/TCR transgenic-PPAR dual reporter mice to 
propose that  VAT Treg development and differentiation is a 2-step process100.  Their 
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findings suggested that thymic Tregs first trafficked to the spleen where those possessing 
VAT antigen-specific TCRs become activated to express low levels of PPAR, KLRG1, 
CD44 and Blimp-1100.  From there, these specific cells proceeded to infiltrate the VAT, 
where they underwent further chromatin remodeling to acquire the entirety of their VAT 
Treg signature which included high expression of PPAR and ST2100.  Utilizing conditional 
knockout mice lacking ST2 specifically in Tregs, they proved that cell-intrinsic IL33-ST2 
signaling was critical for VAT Treg maintenance100.  Furthermore, it appeared that VAT 
Treg accumulation was Foxp3 dependent, as clonotype+ CD4 T effector cells were 
present within the VAT at very low frequencies, but adoptively transferred CD4 T effector 
cells retrovirally transduced to overexpress Foxp3 become enriched in the VAT100. 
Beyond PPARg and Foxp3, ID2 and KLF10 also play important roles in  VAT Treg 
maintenance, differentiation and function.  ID2 is a positive regulator of ST2, CCR2, 
KLRG1 and GATA3 expression, and loss of ID2 leads to increased cell apoptosis and 
decreased IL-10 and IL-13 production101.  In both humans and mice, KLF10 is decreased 
in VAT and scAT Tregs from obese subjects compared to lean subjects102.  In HFD-fed 
mice, adoptively transferred KLF10-deficient splenic Tregs migrated less to the VAT 
compared to adoptively transferred wild-type Tregs.  In induced Tregs, loss of KLF10 
resulted in defective glycolysis and oxidative phosphorylation, and decreased TGFB3 
production102.  With respect to systemic metabolism, mice lacking KLF10+ CD4 T cells 
exhibited greater weight gain, insulin resistance and hepatic steatosis102.   
Besides ID2 and KLF10, there are a number of other candidate transcription 
factors that may shape the VAT Treg compartment.  In obese Stat3f/f CD4-Cre+ mice, 
loss of STAT3 signaling skewed VAT T cells towards a Th1 phenotype over a Treg 
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phenotype, and coincided with increased expression of inflammatory Socs3, Saa3, and 
Ifng within the tissue90.  However, because these mice are CD4-Cre, we cannot rule out 
the possibility that these aTregs were affected in a cell-extrinsic manner by CD8 T cells 
or NKT cells.  In addition, single cell RNA-seq and ATAQ-seq studies have offered the 
bZIP, ETS and NR transcription factor families as possible VAT Treg regulators97. 
 
Figure 2. Phenotype of visceral adipose tissue-resident Tregs in male mice. 
Visceral adipose tissue Tregs in male mice are characterized by the transcription factors: PPARg, FOXP3, 
GATA3, IRF4, BATF, ATF3 and ID2.  In addition, they exhibit a number of extracellular surface markers 
including: ST2, KLRG1, CCR2, CD25 and CXCL2.  VAT Tregs carry out their effector function through 
secretion of IL-10.  Expression of VAT Treg canonical markers can vary depending on whether they reside 























1.4.2 scAT and BAT Treg development, differentiation and maintenance 
Compared to VAT Tregs, less is known about scAT and BAT Treg development, 
differentiation and maintenance.  However, some studies suggest that scAT Tregs are 
less affected by age and obesity.  In one study, the frequency of scAT Tregs only 
underwent a miniscule increase over time from ~10% of CD4 T cells at 5wks of age to 
~15% of CD4 T cells at 20wks of age, unlike the VAT compartment which increased from 
~10% at 5wks of age to ~50% at 20wks of age23.  In addition, in 13wks old leptin-deficient 
obese mice, there was no difference in the scAT Treg frequency between Lepob/+ and 
Lepob/ob mice23.  Maintenance of scAT Tregs does not appear to be PPAR driven, as 
treatment of mice with pioglitazone, a PPAR agonist, resulted in no differences in scAT 
Treg frequency between treated and untreated mice85.  However, similar to VAT Tregs, 
KLF10 is decreased in scAT Tregs from obese humans and mice compared to lean 
subjects, and loss of KLF10 disrupts trafficking of Tregs into the scAT102.  With respect to 
BAT Tregs, as mentioned in the earlier sections, naïve CD4 T cells are induced into Tregs 
through the STAT6/PTEN axis in response to ß-adrenergic signaling94. 
1.5 The role of Blimp-1 transcriptional regulator in Treg development, 
differentiation and function 
B lymphocyte-induced maturation protein-1 (Blimp-1) is a zinc finger motif 
containing transcriptional regulator encoded by the gene positive regulatory domain 1 
(Prdm1)103 that was initially recognized for its role in suppressing IFNß gene 
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expression103, and for regulating plasma cell differentiation104.  However, it is now clear 
that Blimp-1 plays a critical role in development, differentiation, and maintenance of 
various myeloid and lymphoid immune cells including macrophages, dendritic cells and T 
cells105-107. 
Blimp-1 has a far-reaching role in T cells.  During early T cell development, Blimp-
1 deficient mice have fewer thymic T cells at the double-positive and single-positive T cell 
stage, and double-positive cells are more prone to apoptosis108.  In addition, Blimp-1 is 
critical for peripheral T cell homeostasis as loss of Blimp-1 leads to uncontrolled T cell 
expansion and a lethal lymphocyte hyperproliferative syndrome109.  In CD8 T cells, Blimp-
1 determines whether proliferating CD8 T effector cells become terminally differentiated 
into short-lived effector cells, or form into memory precursor effector cells110-112.  Blimp-1 
also positively regulates the expression of cytolytic genes such as Gzmb, Gzmk, and Prf1, 
while repressing expression of Tnfa and Ifng110, 111.  Blimp-1 is not required for  CD8 
memory T cell maintenance, but is critical for an efficient memory recall response during 
viral infections110, 111.  In CD4 T cells, Blimp-1 plays a critical role in CD4 T cell 
differentiation by promoting the transcriptional signature of some subsets, while 
repressing those of others.  In particular, Blimp-1 favors the development, differentiation 
and function of regulatory T cells.  
In an early study by Cretney et al. (2011), Blimp1+/GFP reporter mice and Ly5.1+ 
wild-type Ly5.2+ Blimp-1GFP/GFP mixed bone marrow chimera mice possessing both wild-
type and Blimp-1 deficient Tregs were utilized to study the role of Blimp-1 in effector 
Tregs113.  They found that Blimp-1 was dispensable for splenic effector Treg 
development113.  However, there was a higher frequency of Blimp-1- Tregs than Blimp-
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1+ Tregs in the Peyer’s patches, epithelium and lung, indicating that Blimp-1 is required 
for peripheral Treg homeostasis113.  When infected with influenza, Blimp-1- lung Tregs 
failed to upregulate ICOS pointing towards a role for Blimp-1 in effector Treg  activation113.  
In addition, through a series of in vitro and in vivo experiments involving IL-2—anti-IL-2 
antibody complex injections into Blimp-1+/GFP mice, they demonstrated that IL-2 induced 
Blimp-1, and that its expression could be further enhanced by IL-12, IL-6 and IL-4113.  
Functionally, Blimp-1 was required for IL-10 production113.  Beyond experiments in Blimp-
1 mice, they utilized Ly5.1+ wild-type Ly5.2+ Irf-/- mixed bone marrow chimera mice to 
show that IRF4 directly bound Blimp-1 to positively regulate its expression in Tregs, in 
line with previous observations made in plasma cells, CD8 T cells and total CD4 T cells114, 
115.  IRF4-deficient mesenteric lymph node Tregs had decreased ICOS, CTLA4 and 
CD103 expression indicating that IRF4 is important for Treg differentiation113.  In addition, 
during influenza infection, Tregs required IRF4 to upregulate ICOS and traffic from the 
mediastinal lymph node to the lungs113.  Finally, microarrays confirmed that although 
Blimp-1 and IRF4 worked in concert to dictate effector Treg fate, Blimp-1 was requisite 
for activation, IL-10 production and maintenance in peripheral tissues, whereas IRF4 was 
required for differentiation113. 
In a different study, Bankoti et al. (2017) focused on the role of Blimp-1 in effector 
Treg maintenance, differentiation and function under non-inflammatory conditions.  
Utilizing Blimp-1 reporter mice, they found that Blimp-1 was expressed in ~20-30% of 
splenic, mesenteric lymph node (MLN), and large intestines lamina (LI-LP) Tregs, but in 
only ~5% of thymic Tregs116.  In order to elucidate the role of Blimp-1 in Treg maintenance, 
differentiation and function, they utilized Prdm1f/f Foxp3-Cre+ mice that lacked Blimp-1 
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specifically in Tregs.  Loss of Blimp-1 had no effect of thymic Treg frequency116.  However, 
in the absence of Blimp-1, greater proliferation and decreased cell death resulted in 
higher Treg frequency in the spleen, MLN, and LI-IP116.  In addition, loss of Blimp-1+ 
Tregs increased splenic and MLN CD4 Teffector and CD8 T cells116.  Blimp-1 deficient 
splenic Tregs produced less IL-10116.  However, this was countered by an increase in IL-
10 producing CD4 Teffector cells116.  Loss of Blimp-1+ Tregs had no effect on IL-17 
production by CD4 T cells116.  Hence, in terms of immunopathology, loss of Blimp-1+ 
Tregs led to only mild intestinal inflammation116.  Finally, utilizing microarrays and qPCR, 
they compared how Blimp-1 modulated the transcriptomes of peripheral Tregs versus 
CD4 T effector cells.  Genes that were commonly upregulated by Blimp-1 included: Batf3, 
Bcl6, Prdm1, Slc2a6 and Tox116.  Genes that were commonly down-regulated by Blimp-
1 included: Cd5, Grap2, Il10, Notch1 and Trib2116.  Genes that were uniquely upregulated 
in Blimp-1- Tregs included: Ccr6, Hif1a, Il17f, Stat4 and Tcf7116.  Genes that were uniquely 
down-regulated in Blimp-1- Tregs included: Ctla4, Maf, Socs2, Tbx21 and Tnfrsf18116.  
Tnfrsf18 is the gene which encodes GITR116.  Interestingly, Blimp-1 and GITR appears to 
form an auto-regulatory loop.  In a study by Vasanthakumar et al. (2017), GITR activated 
the transcription factor RelA, and RelA positively regulated Blimp-1 expression 
independent of TCR signaling or IRF4 in effector Tregs117. 
In a follow-up to their 2015 study, Cretney et al. (2018), further examined the cell-
intrinsic effects of Blimp-1 deletion in Tregs, and for the first time described 
immunopathological changes that occurred in older mice that lacked Blimp-1+ Treg.  
Utilizing 8wk old Foxp3RFPPrdm1GFP/+ reporter mice, they found that Blimp-1+ Treg 
frequency was greatest in the colon and small intestines118.  However, Blimp-1+ Tregs 
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were also present in the thymus, blood, spleen, liver, lung, mesenteric and peripheral 
lymph nodes, and Peyer’s patches118.  In addition, from 8wks to 6months of age, the 
frequency of Blimp-1+ Tregs significantly increased in the liver, and decreased in the 
small intestine epithelium118.  Utilizing Prdm1f/f Foxp3-Cre+ mice, they also found that 
Treg-specific deletion of Blimp-1 led to increased blood, thymic, splenic, mesenteric and 
peripheral lymph nodes, lung, Peyer’s patches, and small intestinal epithelium Tregs 
frequency118.  Surprisingly, Blimp-1 deficient splenic Tregs exhibited more of an activated 
phenotype with a higher fraction expressing CD103 or ICOS, and a lower fraction 
expressing CD62L118.  Loss of Blimp-1 led to increased frequency of ICOS+ Tregs in the 
blood, liver, lungs, mesenteric and peripheral lymph nodes, and Peyer’s patches as 
well118.  These findings went against the data in their earlier paper suggesting that Blimp-
1 is required for effector Treg activation113.  However, it was mentioned that their mice 
exhibited “Foxp3-Cre leakiness”, with all of their animals displaying some degree of non-
specific Cre activity in B cells, CD4 T effector cells or CD8 T cells.  With regard to 
immunopathology in aged mice, Prdm1f/f Foxp3-Cre+ mice started to become ill at ~110 
days of age, and none survived past 650 days of age.  In contrast, most wild-type mice 
remained alive118.   In addition, they found higher concentrations of serum antinuclear 
antibodies in 1yr or older knockout mice compared to age-matched wild-type mice118.  
Furthermore, as knockout mice aged, they began exhibiting variable amounts of abnormal 
immunopathology especially in their salivary glands, gastrointestinal tract, and 
pancreas118. 
Expanding on the many known functions of Blimp-1 in Tregs, Ogawa et al. (2018) 
found that it also suppresses IL-17 production in Foxp3+ RORt+ Helios- microbiota-
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specific intestinal mucosa Tregs, and that this occurred independently of IL-10 production 
status119.  In these cells, binding of Blimp-1 to the Il17a and Il17f genes did not prevent 
the positive transcriptional regulator RORt from binding to these genes119.  However, 
Blimp-1 caused inhibitory histone modifications within the Il17 gene119.  In the absence of 
Blimp-1, IRF4 and p300 bound to these genes, and together with RORt upregulated 
IL17a and IL17f.  The end result was failure to prevent gastrointestinal inflammation or 
adoptively transferred colitis119. 
Besides its role in intestinal homeostasis, Garg et al. (2019) found that Blimp-1 can 
indirectly protect Foxp3 expression in central nervous system (CNS) Tregs120.  During 
autoimmune Type 1 diabetes, it was previously shown that Foxp3 could be down-
regulated in Tregs, and that these cells would become pathogenic121.  However, in this 
study, Garg et al. noted that during experimental autoimmune encephalitis, CNS Tregs 
maintained Foxp3 expression as well as their capacity to produce IL-10 despite being in 
an inflammatory environment.  It was also observed that a higher percentage of CNS 
Tregs were Blimp-1+ compared to Tregs from non-inflamed spleen.  It was previously 
shown that, during homeostasis, Foxp3 must be demethylated for it to be stably 
expressed in splenic Tregs122.  In their study, Garg et al. demonstrated that in the absence 
of Blimp-1, DNA methylating enzyme DNMT3A was expressed in an IL-6/STAT3 
dependent manner120.  This reduced chromatin accessibility to Foxp3 leading to 
destabilization of the Treg signature120.  These findings reiterated the importance of 
Blimp-1 in maintaining Treg identity. 
Recently, a study by Vasanthakumar et al. (2020) discovered that male and female 
mice retain distinct VAT Treg signatures.  Blimp-1 was more highly expressed in male 
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VAT Tregs compared to female VAT Tregs80.  In male mice, Treg-specific Blimp-1 
deletion led to fewer VAT Tregs, accompanied by decreased ST2, KLRG1, CCR2 and 
TIGIT expression, and increased CD62L and CD103 expression80.  In addition, loss of 
Blimp-1+ Tregs led to increased glucose intolerance compared to WT mice80.  RNA-seq 
analysis of male VAT Tregs identified numerous genes that were either positively 
regulated (Klrg1, Il1rl1, Il10ra, Ccr2, Il10, Areg, Cd69, Ctla4, Gata3, Pparg, Il5) or 
negatively regulated (Tcf7, S1pr1, Ccr7, Sell, Cxcr3, Icos) by Blimp-180.  ChIP-seq data 
revealed that Blimp-1 directly bound Il10, Ccr2, Il1rl1, Ccr7, Tcf7, Klf2, Cxcr5, S1pr1, Myc 
and Bcl6 in VAT Tregs but with different degrees of chromatin accessibility between male 
and female mice80.  In male VAT, IL-6 was produced primarily by dendritic cells, and to a 
lesser degree by ILC2s and macrophages80.  IL-6 induced Blimp-1 expression in vitro, 
and Il6 deficient mice had fewer ST2+ KLRG1+ CCR2+ VAT Tregs80.  Il6 deficient mice 
also had fewer IL-33 producing stromal cells80.  Injection of IL-33 into Il6 deficient mice 
increased VAT Treg frequency80.  Taken together, this suggested that dendritic cells, 
macrophages and ILC2-derived IL-6 sustained IL-33 producing stromal cells, and that IL-
33/ST2 signaling promoted VAT Treg maintenance. 
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Figure 3. Phenotype of Blimp-1+ Tregs. 
B lymphocyte-induced maturation protein-1 (Blimp-1) is induced by T cell receptor activation in the presence 
of IL-2.  However, its expression can be enhanced by additional cytokines including IL-4, IL-12 and IL-6.  
Blimp-1 is encoded by the gene Prdm1, and its transcription is regulated by RelA and IRF4.  Furthermore, 
dual binding of Blimp-1 and IRF4 can induce IL-10 expression in Tregs. 
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2.0 The role of Blimp-1 in adipose-resident Tregs 
2.1 Introduction 
Adipose-resident Tregs protect against systemic inflammation and metabolic 
disease by limiting expansion of pro-inflammatory cells, preserving insulin sensitivity and 
maintaining glucose tolerance.  Although their basic markers and roles have been 
studied, less is known about the transcriptional machinery regulating their differentiation 
and function.  For this project, I decided to investigate the role of B lymphocyte-induced 
maturation protein-1 (Blimp-1) transcriptional regulator since it interacts with Id proteins, 
which our lab has previously found a role for in adipose Treg survival and maintenance.  
To study this question, we placed male Prdm1f/f Foxp3-YFP-Cre+ conditional knockout 
mice (CKO) lacking Blimp-1 specifically in Tregs and wild-type (WT) litter mate controls 
on either standard chow (SFD) or high fat diet (HFD), aged them out to 26-28wks, then 
compared Tregs from various adipose depots as well as the metabolic phenotype of the 
different mice.  I hypothesized that: 1) Blimp-1 is required for adipose Treg maintenance, 
differentiation and function, and that 2) Blimp-1+ Tregs help preserve insulin sensitivity 
and glucose tolerance. 
Portions of the following chapter are taken or adapted from the publication: Beppu, 
L. Y., Mooli, R., Qu, X., Marrero, G. J., Finley, C. A., Fooks, A. N., Mullen, Z. P., Frias, A. 
B., Jr, Sipula, I., Xie, B., Helfrich, K. E., Watkins, S. C., Poholek, A. C., Ramakrishnan, S. 
K., Jurczak, M. J., & D'Cruz, L. M. (2021). Tregs facilitate obesity and insulin resistance 
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via a Blimp-1/IL-10 axis. JCI insight, 6(3), e140644. 
https://doi.org/10.1172/jci.insight.140644  
2.2 Materials and methods 
2.2.1 Study design  
The objective of this study was to interrogate the function of IL-10 and Blimp-1 
expression by adipose-resident Tregs in mice on SFD and HFD. To do this, we used a 
combination of in vivo and ex vivo assays on mouse samples. We designed and 
performed the experiments predominantly using flow cytometry and metabolic indices for 
our analysis. The number of replicates for each experiment is indicated in the figure 
legends.  
2.2.2 Mice 
C57BL/6 mice were purchased from The Jackson Laboratory. Blimp-1–YFP 
(commercially available at Jackson, stock number 008828), Foxp3-RFP (commercially 
available at Jackson, stock number 008374)123, and Blimp-1fl/fl mice (commercially 
available at Jackson, stock number 008100)124 were donated by A. Poholek (University 
of Pittsburgh). Il10fl/fl mice were donated by D. Vignali (University of Pittsburgh). Foxp3-
YFP-Cre mice were purchased from The Jackson Laboratory (stock number 016959)125. 
All experiments were approved by the University of Pittsburgh Institutional Animal Care 
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and Use Committee. All mice used in experiments were age-matched littermate males 
between 26 and 28 weeks of age. Male mice were used due to the hormonal fluctuations 
that occur in female mice. Where indicated, mice were fed either SFD (standard chow) or 
HFD (60% kcal fat, Teklad, Envigo, TD06414) from 8 weeks of age until 26–28 weeks of 
age. Male animals were assigned to groups of 3–7 mice per experiment where possible, 
and at least 2 independent experiments were performed throughout the study. Mice were 
bred and housed in specific pathogen–free conditions in accordance with the Institutional 
Animal Care and Use Guidelines of the University of Pittsburgh. Mice were maintained at 
approximately 22°C room temperature as standard. 
2.2.3 Cell isolation 
Murine epididymal, inguinal, and brown adipose single-cell suspensions were 
prepared as previously described (45). Briefly, tissue was harvested, weighed, finely 
chopped with a razor blade, and digested with Liberase TM and DNase I (MilliporeSigma) 
at 37°C with shaking for 30 minutes before filtering through a 70 μm nylon mesh and 
centrifugation for 5 minutes at 4°C. The supernatant was removed and the SVF was 
isolated and processed for flow cytometry. Single-cell suspensions of spleen and iLN cells 
were made by processing murine spleens between 2 glass slides. 
2.2.4 Flow cytometry 
Antibodies against murine CD4 (RM4-5, AF700, BV650), CD8 (53-6.7, APC/Fire 
750, BV785), CCR2 (SA203G11, BV421), CD11c (N418, APCCy7, Pe/Cy5), CD206 
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(C068C2, APC), CD11b (M1/70, BV421), F4/80 (BM8, BV510, BV711, FITC), TCRβ 
(H57-597, BV605), and NK1.1 (PK136, BV650) were purchased from BioLegend. 
Antibodies against CD4 (GK1.5, BUV395) and ST2 (U29-93, BV480) were purchased 
from BD Biosciences. Antibodies against B220 (RA3-6B2, AF488), CD11c (N418, e450, 
PE-Cy5.5), CD25 (PC61.5, PE-Cy7), CD4 (GK1.5, APC-eFluor 780, Super Bright 645), 
CD45 (30-F11, Pacific Orange), Foxp3 (FJK-16s, APC, e450, FITC), GITR (DTA-1, Super 
Bright 600), IL-10 (JES5-16E3, PE), KLRG1 (2F1, APC, APC-eFluor 780, PE-eFluor 610), 
NK1.1 (PK136, PE), and ST2 (RMST2-2, PE, PerCP-eFluor710) were purchased from 
eBioscience, Thermo Fisher Scientific. Viability dyes (e506, near IR, UV) were purchased 
from Invitrogen, Thermo Fisher Scientific. Extracellular flow staining was performed in 2% 
FBS-PBS in the presence of BioLegend’s TruStain FcX for 30 minutes at 4°C. Fixation, 
permeabilization, and intracellular staining were performed using eBioscience’s (Thermo 
Fisher Scientific) Foxp3/transcription factor staining buffer set per manufacturer’s 
directions. Flow data were collected using a Cytek Aurora or BD Biosciences LSR and 
analyzed using FlowJo. 
2.2.5 Intracellular cytokine analysis 
For intracellular cytokine staining total SVF was stimulated with PMA (50 ng/mL) 
(MilliporeSigma) and ionomycin (1 nM) (MilliporeSigma) for 5 hours. Brefeldin A 
(eBioscience, Thermo Fisher Scientific) was added to the culture at the recommended 
concentration. Cells were surfaced stained, before fixing, permeabilizing, and intracellular 
staining according to the manufacturer’s instructions (eBioscience, Thermo Fisher 
Scientific, Foxp3/transcription factor staining kit).  
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2.2.6 Determination of fasting blood glucose, glucose tolerance testing (GTT), and 
insulin tolerance testing (ITT) 
Mice were fasted overnight before fasting blood glucose and insulin levels were 
measured. Blood glucose was measured using a handheld glucometer (Bayer Contour 
Next), and plasma insulin was measured by ELISA (Alpco). For the GTTs, we 
administered glucose (2 g/kg of body weight) by i.p. injection after an overnight fast. We 
measured changes in plasma insulin at 15, 30, and 120 minutes and blood glucose at 15, 
30, 45, 60, and 120 minutes after glucose injection. For the ITT, mice were fasted for 6 
hours before intravenous injection with 0.75 U/kg of body weight Novolin-R human 
recombinant insulin (Henry Schein). After insulin injection, blood glucose was measured 
at 15, 30, 45, 60, and 120 minutes.  
2.2.7 Indirect calorimetry and body composition measurements 
Indirect calorimetry was performed using the Promethion Multiplexed Metabolic 
Cage System (Sable Systems) by the University of Pittsburgh Center for Metabolism and 
Mitochondrial Medicine. Animals were placed individually in chambers for 24 hours to 
acclimate followed by 48 hours at ambient room temperature with 12-hour light/12-hour 
dark cycles for analysis. Animals had free access to food and water. Respiratory 
measurements (VO2 /VCO2 ) were made at 5-minute intervals. Food intake was 
measured in metabolic chambers during the 48-hour period. Body composition including 
fat and LM was determined using by EchoMRI. Mice were weighed twice per month to 
determine weight increases over time on SFD and HFD. 
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2.2.8 Tissue H&E staining 
Tissues were placed in cassettes and submerged in 10% formalin solution 
overnight. Tissue cassettes were washed with tap water for 15 minutes and stored in 70% 
ethanol at room temperature. Paraffin embedment and sectioning (4–5 μm thickness) was 
performed by StageBio. Slides were deparaffinized and rehydrated using ethanol and 
PBS, respectively. H&E staining was performed using hematoxylin for 5 minutes followed 
by eosin for 15 seconds. The images were acquired by using an Evos fluorescence 
inverted microscope.  
2.2.9 Reverse transcription quantitative PCR analysis 
Total RNA was extracted using RNeasy Lipid Tissue Mini Kit (Qiagen) as per the 
manufacturer’s instructions. First 1 μg of total RNA was reversed-transcribed using Mu-
MLV reverse transcriptase (Promega). Gene expression was evaluated by quantitative 
real-time PCR using SYBR Green Mastermix (Radiant Molecular Tools) with a Quant 
Studio 3 Station quantitative PCR machine (Applied Biosystems, Thermo Fisher 
Scientific). The results were expressed as fold change using the 2-ΔΔCT method, and β-
actin was used as an internal normalization control. A list of the primer sequences used 
is provided in Supplemental Table 1.  
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Table 1. Real-time PCR primers 
Gene Forward (5’-3’) Reverse (5’-3’) 
Ucp1 GGCCTCTACGACTCAGTCCA TAAGCCGGCTGAGATCTTGT 
Prdm16 CAGCACGGTGAAGCCATTC GCGTGCATCCGCTTGTG 
Cidea ATCACAACTGGCCTGGTTACG TACTACCCGGTGTCCATTCT 
Dio2 CATGCTGACCTCAGAAGGGC CCCAGTTTAACCTGTTTGTAGGCA 
AdipoQ GCACTGGCAAGTTCTACTGCAA GTAGGTGAAGAGAACGGCCTTGT 
Fabp4 ACAAGCTGGTGGTGGAATGTG CCTTTGGCTCATGCCCTTT 
Plin2 CTCAGGAGGAGCTGGAGATG TCAATCAGGTGGACAGTGGA 
Pparg AGGCGAGGGCGATCTTGACAG AATTCGGATGGCCACCTCTTTG 
-actin TATTGGCAACGAGCGGTTCC GGCATAGAGGTCTTTACGGATGT 
 
2.2.10 Western blotting 
Protein extracts were prepared as previously described126. In brief, the adipose 
tissue samples were lysed in radioimmunoprecipitation assay lysis buffer (50 mM Tris pH 
7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-40) supplemented with protease and 
phosphatase inhibitors (MilliporeSigma). The protein content was measured by using 
protein assay kit (Bio-Rad). The protein lysates (20–25 μg) were resolved on 9%–12% 
polyacrylamide gels and transferred to nitrocellulose membranes. Membranes were 
blocked with 5% skim milk powder in Tris-buffered saline containing 0.01% Tween 20 and 
probed with primary antibodies (UCP1, PAI-24894, Invitrogen, Thermo Fisher Scientific; 
PRDM16, NBP1-77096, Novus Biologicals; β-actin, 66009-I-Ig, Proteintech) overnight at 
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4°C. Membranes were then probed with respective secondary antibodies — anti-rabbit 
IgG (H+L) DyLight800, Cell Signaling Technology, catalog 5151S, and anti-mouse IgG 
(H+L) DyLight680, Cell Signaling Technology, catalog 5470S) and visualized using 
Odyssey CLx Imaging System (LI-COR). The Western blot images were quantified by 
using ImageJ software (NIH, Bethesda, Maryland, USA). 
2.2.11 Cell culture and IL-10 in vitro assay 
Mouse inguinal adipose-derived SVF preadipocytes (Kerafast, Inc.) were provided 
in-house (University of Pittsburgh). Cells were grown to confluence in DMEM/F12 with 
10% FBS and 1% penicillin-streptomycin. One day prior to differentiation, cells were 
subcultured into a 12-well plate at 70% confluence and allowed to rest overnight. The 
cells were differentiated into brown adipocytes with the cocktail of 0.5 mM 
isobutylmethylxanthine, 125 nM indomethacin, 2 μg/mL dexamethasone, 850 nM insulin, 
1 nM T3, and 0.5 μM rosiglitazone. After 2 days, cells were placed into postdifferentiation 
maintenance media consisting of complete media with 850 nM insulin, 1 nM T3, and 0.5 
μM rosiglitazone. After an additional 2 days, cells were treated for 16 hours with 100 
ng/mL recombinant mouse IL-10 (R&D Systems, Bio-Techne) for downstream real-time 
PCR analysis. 
2.2.12 Statistics 
All graphs were created using GraphPad Prism 8, and statistical significance was 
determined with the 2-tailed paired or unpaired Student’s t test or using 1-way ANOVA 
 37 
adjusted for multiple comparisons where appropriate. We used a P value of less than 
0.05 as statistically significant. The graphical abstract was created using BioRender.com.  
2.2.13 Study approval 
All rodent breeding and experimental procedures were approved by and performed 
in accordance with the guidelines of the Institutional Animal Care and Use Committee of 
the University of Pittsburgh and complied with the NIH Guide for the Care and Use of 
Laboratory Animals (National Academies Press, 2011). 
2.3 Results 
2.3.1 Blimp-1+ Tregs are present in the adipose tissue and are phenotypically 
distinct from their Blimp-1- counterparts 
Previously published research has found that Blimp-1 is highly expressed in 
visceral adipose tissue (VAT) Tregs compared to Tregs from secondary lymphoid organs 
or other peripheral tissues92, 127. To verify these data, epididymal VAT Tregs and splenic 
Tregs were isolated from male Blimp-1YFPFoxp3RFP dual reporter mice. Whereas, 25% of 
splenic Tregs were positive for Blimp-1, 50% of VAT Tregs were positive for Blimp-1 (Fig. 
1A). Next, Blimp-1+ versus Blimp-1- VAT Tregs were compared for expression of 
canonical effector Treg markers. ST2 is the receptor for IL-33, which is known to play an 
important role in maintenance and expansion of adipose Tregs (aTreg)91, 92, 96, 128.  KLRG1 
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is a marker of antigen-experienced Tregs129, and is known to be highly expressed in 
aTregs relative to splenic Tregs85. There was a statistically significant increase in KLRG1, 
and a trend towards increased ST2 in the Blimp-1+ VAT Tregs compared to their Blimp-
1- counterparts (Fig. 1B). CD25, the alpha portion of the IL-2 receptor, has also been 
previously shown to be highly expressed in VAT Tregs compared to splenic Tregs23. In 
addition, CD25 has been shown to play a critical role in maintaining peripheral Treg 
identity and protection from apoptosis130. Furthermore, it has previously been shown in 
peripheral lymphoid Tregs that Blimp-1 expression correlates negatively with CD25 
expression113. Similarly, our Blimp-1+ VAT Tregs expressed lower levels of CD25 
compared to Blimp-1- VAT Tregs (Figure 1C). Taken together, these data suggested that 
Blimp-1+ Tregs are a unique subpopulation of VAT effector Tregs. 
 39 
 
Figure 4. Blimp-1+ VAT Tregs possess a unique effector Treg signature.  
Analysis of visceral adipose tissue (VAT) and splenic Tregs from 15-week-old male Blimp-1YFPFoxp3RFP 
dual reporter mice on 20% standard fat diet. (A) Representative flow plots and frequency of Blimp-1+ versus 
Blimp-1- Foxp3+ Tregs in VAT versus spleen. Cells were gated off total CD4 T cells. (B-C) Representative 
histograms and MFI quantification of ST2, KLRG1 and CD25 expression by Blimp-1+ (grey line) versus 
Blimp-1- (black line) VAT Tregs. Cells were gated off CD4+ Foxp3+ T cells. Data are presented as means 
± SEM for n = 11 mice per group (A, C) or n = 6 mice per group (B), pooled from four independent 
experiments. Paired Student’s t-test was used (n.s. = not significant). 
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2.3.2 The role of Blimp-1 in adipose Treg maintenance, differentiation and 
function 
Next, we wanted to determine whether or not Blimp-1 plays a critical role in VAT 
Treg maintenance, differentiation and function. To do so, we utilized Prdm1f/f CD4-Cre+ 
mice lacking Blimp-1 in all CD4 and CD8 T cells. There were no differences in VAT or 
splenic Treg frequency or total cell count between Blimp1f/f CD4-Cre+ VS wild-type  
control mice (Fig. 2A). However, loss of Blimp-1 led to reduced ST2 and KLRG in VAT 
Tregs but not splenic Tregs (Fig. 2B). In addition, CCR2, a chemokine receptor known to 
be highly expressed in VAT Tregs compared to lymphoid Tregs23, 85 was also 
downregulated in the absence of Blimp-1 (Fig. 2B). Although these data suggested 
Blimp-1 may play an important role in maintaining the VAT Treg signature, the use of the 
CD4-Cre system (and thus loss of Blimp-1 in all conventional T cells) prevented us from 
determining whether this was occurring in a cell-intrinsic or cell-extrinsic manner. 
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Figure 5. Loss of Blimp-1 disrupts the VAT Treg signature in Prdm1f/f CD4-Cre+ mice. 
Analysis of VAT and splenic Tregs from 26-28-week old male Prdm1f/f CD4-Cre+ (CKO) or wild-type 
littermate control (WT) mice on 20% standard fat diet. (A) Representative flow plots and quantification of 
VAT and splenic Treg frequency and total cell count. Cells gated off total CD4 T cells. (B) Representative 
flow plots of VAT Tregs expressing ST2, KLRG1, and CCR2 (left), and frequency of these markers in VAT 
and splenic Tregs (right). Cells gated off CD4+ Foxp3+ T cells. Data are presented as means ± SEM for n 
= 10 mice per group (A) or n = 6 mice per group (B), pooled from four independent experiments. Unpaired 
Student’s t-test was used (n.s. = not significant). 
 
To determine whether Blimp-1 maintained the VAT Treg signature in a cell-intrinsic 
manner, we next analyzed Prdm1f/f Foxp3-YFP-Cre+ conditional knockout (CKO) mice 
lacking Blimp-1 in all Tregs under standard fat diet (SFD) and high fat diet (HFD) 
conditions. Under SFD conditions, Treg-specific deletion of Blimp-1 led to reduced 
frequency of VAT Tregs but not splenic Tregs (Fig. 3A). When comparing CKO mice to 
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their WT counterparts, the former had fewer ST2+ and KLRG1+ VAT Tregs but exhibited 
no differences in splenic Tregs (Fig. 3B). In addition to ST2 and KLRG1, the frequency 
of CCR2+ and GITR+ Tregs were examined as well. CCR2 is a chemokine receptor 
important for leukocyte migration into peripheral tissue, and has been shown to be more 
highly expressed in aTregs compared to splenic Tregs or conventional T cells in either 
tissue23. GITR has been shown to be important in Treg expansion and function131, and is 
known to be up-regulated in Tregs when co-cultured in the presence of adipose tissue 
macrophages132.  The absence of Blimp-1 led to reduced GITR+ and CCR2+ aTregs but 
not splenic Tregs (Fig. 3B).  Finally, we wanted to see whether Blimp-1 plays a role in 
VAT Treg function. Blimp-1 has previously been shown to positively regulate IL-10 
expression in Tregs113, 116. To test whether Blimp-1 is required for IL-10 production in VAT 
Tregs, we isolated the stromal vascular fraction from the VAT, and stimulated it ex vivo. 
As expected, Blimp-1 deficiency led to diminished IL-10 production by VAT Tregs (Fig. 
3C). Taken together, these data indicated that Blimp-1 can regulate the VAT Treg 
signature under SFD conditions in a cell-intrinsic manner, and that Blimp-1 can uniquely 




Figure 6. Loss of Blimp-1 disrupts the VAT Treg phenotype in lean Prdm1f/f Foxp3-YFP-Cre+ mice. 
Analysis of VAT and splenic Tregs were from 26-28wk old male Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-
type littermate controls (WT) mice on 20% standard fat diet (SFD). (A) Representative flow plots and 
quantification of Treg frequency and total cell count per gram tissue. Cells gated off total CD4 T cells. (B) 
Representative flow plots and frequency of ST2, CCR2, GITR and KLRG1 positive Tregs. Cells gated off 
CD4+ Foxp3+ T cells. (C) Total VAT stromal vascular fraction was stimulated ex vivo for 5 hours with PMA 
and ionomycin. Representative flow plots and quantification of IL-10 producing VAT Tregs. Cells gated off 
CD4+ Foxp3+ T cells. Data are presented as means ± SEM and are pooled from 2-3 independent 
experiments with n=4-8 per group. Unpaired Student’s t-test or one-way ANOVA were used (n.s. = not 
significant). 
 
In addition to VAT, immune cells also reside in the subcutaneous inguinal white 
adipose tissue (iWAT)94, 133-135 as well as the interscapular brown adipose tissue (BAT)82, 
94. Thus, we decided to analyze Treg frequency and markers in these tissues as well. In 
the absence of Blimp-1, there was no difference in the frequency of iWAT or BAT Tregs 
(Fig. 4A).  However, there was an increase in Treg frequency within the inguinal lymph 
node (iLN) (Fig. 4A). In addition, loss of Blimp-1 led to reduced frequency of ST2+ iWAT, 
BAT and iLN Tregs (Fig. 4B).  Furthermore, Blimp-1 deficiency led to decreases in 
KLRG1+ iWAT and BAT Tregs (Fig. 4C). We also measured IL-10 production in IAT and 
iLN Tregs, and observed reductions in IL-10 production in the absence of Blimp-1 (Fig. 
4D). Although we attempted to measure IL-10 production in BAT Tregs, we did not have 
enough viable cells post-stimulation to make definitive conclusions. 
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Figure 7. Loss of Blimp-1 disrupts the IAT and BAT Treg phenotype in lean Prdm1f/f Foxp3-YFP-
Cre+ mice. 
Analysis of IAT, BAT and iLN Tregs from 26-28wk old male Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type 
littermate controls (WT) mice on 20% standard fat diet (SFD). (A) Treg frequency in indicated tissue. Cells 
gated off total CD4+ T cells. (B-C) Frequency of ST2+ and KLRG1+ Tregs in indicated tissue. Cells gated 
off CD4+ Foxp3+ T cells. (D) Total IAT and iLN stromal vascular fractions were stimulated ex vivo for 5 
hours with PMA and ionomycin. Quantification of IL-10 producing IAT and iLN Tregs. Cells gated off CD4+ 
Foxp3+ T cells. Data are presented as means ± SEM and are pooled from 2 independent experiments with 
n=5-9 per group for (A-C) and n=5-8 per group for (D). One-way ANOVA was used (n.s. = not significant). 
 
Next, we compared the VAT Treg signature of Blimp-1 CKO mice VS WT mice on 
HFD. Eight-week-old mice were placed on 60% HFD and analyzed at 26-28wks of age. 
Treg-specific deletion of Blimp-1 did not result in any changes in VAT or splenic Treg 










































































































total number of Tregs (Fig. 5A). Similar to the Blimp-1 deficient VAT Tregs from lean 
mice, Blimp-1 deficient VAT Tregs from obese mice had decreased levels of ST2, CCR2, 





Figure 8. Loss of Blimp-1 disrupts the VAT Treg phenotype in obese Prdm1f/f Foxp3-YFP-Cre+ 
mice. 
Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed on 60% high 
fat diet (HFD) starting at 8wks of age and analyzed after 18-20wks on HFD. (A) Representative flow plots 
and quantification of splenic and VAT Treg frequency and total cell count per gram tissue. Cells gated off 
total CD4 T cells. (B) Representative flow plots of ST2, CCR2, GITR and KLRG1 positive VAT Tregs (top) 
and quantification of markers expressed by splenic and VAT Tregs (bottom). Cells gated off CD4+ Foxp3+ 
T cells. (C) Total VAT stromal vascular fraction was stimulated ex vivo for 5 hours with PMA and ionomycin. 
Representative flow plots and quantification of IL-10 producing VAT Tregs. Cells gated off CD4+ Foxp3+ T 
cells. Data are presented as means ± SEM and are pooled from 2-3 independent experiments with n=5-14 
per group. Unpaired Student’s t-test or one-way ANOVA were used (n.s. = not significant). 
 
In addition to analyzing VAT Tregs, we also analyzed Tregs from the IAT, BAT and 
iLN of HFD-fed mice. Whereas loss of Blimp-1 had no effect on IAT Treg frequency, BAT 
and iLN Treg frequency increased in the absence of Blimp-1 (Fig. 6A). Similar to IAT and 
BAT Tregs from lean mice, Blimp-1 deficiency led to decreased frequency of ST2+ IAT 
and BAT Tregs (Fig. 6B). In addition, loss of Blimp-1 led to a lower percentage of KLRG1+ 
IAT Tregs (Fig. 6C). Finally, loss of Blimp-1 led to decreased IL-10 production by IAT and 
iLN Tregs (Fig. 6D). 
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Figure 9. Loss of Blimp-1 disrupts the IAT and BAT Treg phenotype in obese Prdm1f/f Foxp3-YFP-
Cre+ mice 
Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed on 60% high 
fat diet (HFD) starting at 8wks of age and analyzed after 18-20wks on HFD. (A) Treg frequency in indicated 
tissue. Cells gated off total CD4+ T cells. (B-C) Frequency of ST2+ and KLRG1+ Tregs in indicated tissue. 
Cells gated off CD4+ Foxp3+ T cells. (D) Total IAT and iLN stromal vascular fractions were stimulated ex 
vivo for 5 hours with PMA and ionomycin. Quantification of IL-10 producing IAT and iLN Tregs. Cells gated 
off CD4+ Foxp3+ T cells. Data are presented as means ± SEM and are pooled from 2 independent 
experiments with n=4-8 per group for (A-C) and n=5-8 per group for (D). One-way ANOVA was used (n.s. 
= not significant). 
2.3.3 The role of Blimp-1+ Tregs in protection against obesity 
Previous research have suggested that VAT Tregs play an important role in 






































































































Tregs have been implicated in helping maintain insulin sensitivity and glucose tolerance 
in obese mice23, 91, 92, 128, 136. Prior to visiting the role of VAT Tregs in maintaining metabolic 
homeostasis in obese mice, we decided to first examine how our Prdm1f/f Foxp3-YFP-
Cre+ mice fared under standard chow. In 26-28wk old mice, the CKO mice appeared 
slightly leaner (Fig. 7G), but overall, there was no statistically significant difference in 
body weight, fasting insulin or fasting glucose levels between the two experimental groups 
(Fig. 7A-C). However, when a intraperitoneal glucose tolerance test was conducted after 
a 6hr fast, CKO mice exhibited lower levels of circulating glucose from 45 minutes to 2 
hours post-injection, and lower levels of circulating insulin at 2 hours post-injection (Fig. 
7D-E). In addition, an insulin tolerance test after a 6 hour fast was performed. The CKO 
mice exhibited lower levels of circulating glucose as early as 15 minutes post-injection 
with insulin (Fig. 7F). 
Next, EchoMRI was utilized to analyze the body fat composition of the mice were 
analyzed using EchoMRI. CKO mice had a slightly lower overall body weight compared 
to WT mice although the difference was not statistically significant (Fig. 7I). However, fat 
mass of CKO mice was less than their WT counterparts, and hence CKO mice had a 
percent body composition consisting of higher lean mass, and lower fat mass compared 
to WT mice (Fig. 7I).  
Next, mice were housed in metabolic cages to analyze their metabolism over the 
course of 48hrs. We observed that the CKO mice ate more (Fig. 7J). However, they were 
also more active than the WT mice during the light cycle (Fig. 7K). Respiratory exchange 
ratio (RER) is the ratio of CO2 volume exhaled to the oxygen volume inhaled, and can be 
used to determine the type of substrate being utilized during aerobic respiration where 
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values closer to 1 indicate glucose oxidation, and values closer to 0.7 mark fatty acid 
oxidation137. The CKO mice had a higher RER compared to WT mice during both the light 
and dark cycles indicating that they were utilizing glucose as their main energy source 
(Fig. 7L). 
 Finally, we examined the gross anatomy of the mice.  The inguinal white adipose 
tissue (IAT) was slightly smaller, and the VAT were clearly smaller in the CKO mice 
compared to the WT mice (Fig. 7G). In addition, the liver of the CKO mice was a darker 
color of red compared to the WT mice suggesting that these mice had less hepatic 
steatosis (Fig. 7G). Taken together, these observations suggested that mice lacking 
Blimp-1+ Tregs had less fat deposition. However, one concern we had was that this could 
be due to poor nutrient absorption. As demonstrated in Fig. 3, Blimp-1 deficient Tregs 
produce less IL-10. It has previously been shown that total IL-10 deficiency and Treg-
specific IL-10 deletion can lead to colitis125, 138-140. Thus, we measured the colon length of 
our Blimp-1 CKO mice for signs of inflammation but we observed no difference between 
the WT and CKO mice (Fig. 7H). From these data combined, we concluded that Blimp-





Figure 10. Treg-specific deletion of Blimp-1 leads to decreased fat mass and improved insulin 
sensitvity in lean mice. 
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 20% standard fat diet (SFD) for 18-20 weeks prior to metabolic analysis. (A) Body weight of 26-28-week-
old WT and CKO mice. (B-C) Fasting plasma insulin and glucose levels. (D-E) Intraperitoneal glucose 
tolerance test. Plasma insulin and blood glucose levels over time post-glucose injection. Bar graphs 
represent area under the curve (AUC). (F) Intraperitoneal insulin tolerance test. Plasma glucose over time 
post-insulin injection. Bar graph indicates AUC. (G) Gross appearance, inguinal WAT (iWAT), epididymal 
visceral WAT (VAT) and livers. (H) Photographs and quantification of colon length. (I) Body composition as 
measured by EchoMRI. (J-L) Mice were placed in Promethion Multiplexed Metabolic Cage System for 48hrs 
and measurements recorded in 5-minute increments during 12hr light/dark cycles. (J) Food intake in grams 
(g) per kilogram (kg) lean mass (LM). (K) Total activity in meters (m) over 48 hours. (L) Respiratory 
exchange ratio (RER) where 0.7 indicates fatty acid oxidation and 1.0 indicates glucose oxidation. Data are 
presented as means ± SEM and are pooled from 2-3 independent experiments for A-G. Each dot represents 
one mouse. Unpaired Student’s t-test or one-way ANOVA were used (*=P value <0.05). 
 
We next moved on to analyzing Prdm1f/f Foxp3-YFP-Cre+ mice in a diet-induced 
obesity model. We first placed 8-week-old male mice on 60% high fat diet (HFD), and 
measured weight gain over time. Up until 4 wks on HFD, both WT and CKO mice gained 
weight at the same rate. However, from that point forward, CKO mice gained weight at a 
slower rate than their WT counterparts (Fig. 8). 
 54 
 
Figure 11. Weight gain in WT and Prdm1f/f Foxp3-YFP-Cre+ mice over time. 
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD), and their weight gain tracked over time. Data are presented as means ± SEM 
with n=12-14 per group pooled from two independent experiments. Unpaired Student’s t-test was performed 
(n.s.= not significant). 
 
At 26-28wks of age, the CKO mice exhibited lower body weight compared to the 
WT mice (Fig. 9A). Analysis of body weight composition by EchoMRI confirmed this 
difference in body weight, and revealed that it was attributable to decreases in fat mass 
(Fig. 9H). These differences were also observable by looking at the gross anatomy of the 
mice.  The CKO mice were visible leaner than their WT counterparts (Fig. 9L). In addition, 
their inguinal and visceral fat pads were smaller than those of the WT mice (Fig. 9L). In 
addition, the liver of the CKO mice were darker in color suggesting less hepatic steatosis 
(Fig.9L). Examination of the colon revealed no signs of inflammation, or differences in 
colon length between WT and CKO mice suggesting that the difference in weight was 
unlikely to be a result of colitis or nutrient malabsorption (Fig. 9M).  
When fasting glucose and insulin were measured, both were lower in the CKO 
mice resulting in overall decreased fasting insulin resistance as measured by HOMA-IR 
(Fig. 9B-D). During glucose tolerance tests, circulating insulin was greater in the WT mice 
compared to CKO mice  (Fig. 9E).  In addition, circulating plasma glucose was slightly 
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lower in the CKO mice throughout the time course, although it was not statistically 
significant (Fig. 9F). We also performed an insulin tolerance test, but we did not see a 
difference in circulating glucose (Fig. 9G).  Because the HFD-fed mice displayed 
hyperinsulinemia compared to the SFD-fed mice (Fig. 7D, Fig. 9E), this suggested that 
perhaps a higher dose of glucose needed to be injected during the glucose and insulin 
tolerance tests to see an observable difference in circulating glucose uptake.   
Finally, mice were house in metabolic chambers for 48hrs. CKO mice ate less, but 
exhibited no differences in activity compared to the WT mice (Fig. 9I-J). During the light 
cycle, CKO mice had a lower RER indicating that fat oxidation was preferential to 
carbohydrate use (Fig. 9K). 
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Figure 12. Loss of Blimp-1+ Tregs protects mice against diet-induced obesity. 
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 18-20 weeks prior to metabolic analysis. (A) Body weight of 26-28-week old 
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HFD-fed WT and CKO mice. (B-C) Fasting plasma insulin and glucose levels in WT and CKO mice. (D) 
Fasting insulin resistance as measured by homeostatic model assessment of insulin resistance (HOMA-IR) 
in WT and CKO mice. (E-F) Intraperitoneal glucose tolerance test. Plasma insulin and blood glucose levels 
over time post-glucose injection. Bar graphs represent area under the curve (AUC). (G) Intraperitoneal 
insulin tolerance test. Plasma glucose over time post-insulin injection. Bar graph indicates area under the 
curve (AUC). (H) Body composition as measured by EchoMRI. (I-K) Mice were placed in Promethion 
Multiplexed Metabolic Cage System for 48hrs and measurements recorded in 5-minute increments during 
12hr light/dark cycles. (I) Food intake in grams (g) per kilogram (kg) lean mass (LM). (J) Total activity in 
meters (m) over 48 hours. (K) Respiratory exchange ratio (RER) where 0.7 indicates fatty acid oxidation 
and 1.0 indicates glucose oxidation. (L) Gross appearance, inguinal WAT (iWAT), epididymal visceral WAT 
(VAT) and livers. (M) Top: Photographs and quantification of colon length. Bottom: H&E stain of colon 
cross-section. Data are presented as means ± SEM and are from 2–3 independent experiments with 3–12 
mice, where each dot represents 1 mouse, and an unpaired 2-tailed Student’s t test or 1-way ANOVA was 
performed to determine significance (*=P value <0.05). 
2.3.4 The role of Blimp-1+ Tregs in maintenance of other adipose-resident 
immune cells 
Initially, we hypothesized that disruption of the aTreg signature would lead to 
increased inflammation and poor metabolic outcomes as Tregs have been shown to be 
critical for glucose tolerance and insulin sensitivity23, 89-91, 93. However, our data indicated 
that disrupting the aTreg signature led to reduced body weight and improved insulin 
sensitivity. We also observed that loss of Blimp-1 in VAT, iWAT and BAT Tregs lead to 
reduced ST2, the receptor for IL-33, on these cells. ST2 is expressed by a multitude of 
innate and adaptive immune cells across multiple inflammatory disease models141. In 
adipose tissue, it has been shown that macrophages express ST2, and that IL-33 
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administration can reduce total VAT F4/80+ cell frequency in HFD mice91. In ob/ob mice, 
IL-33 administration can increase the frequency of total F4/80+ cells in the VAT, and lead 
to higher accumulation of alternatively activated CD206+ M2 macrophages compared to 
classical TLR2+ M1 macrophages136. In short-term HFD fed mice, total IL-33 deficient 
mice also exhibit increased total VAT macrophages and dendritic cells20. Recent research 
have found that macrophages can directly impact insulin resistance and glucose 
tolerance142-145. Hence, we hypothesized that Blimp-1-deficient Tregs lacking ST2 may 
uptake less IL-33, which could divert more of this cytokine to. However, when total F4/80+ 
macrophages were analyzed, there was no difference in their frequency between CKO 
and WT mice (Fig. 10B). Adipose tissue macrophages have classically been categorized 
as M1 pro-inflammatory or M2 anti-inflammatory macrophages with the former linked to 
insulin resistance, and the latter associated with insulin resistance146. When we examined 
the relative frequencies of CD11c+ M1 macrophages, and CD206+ M2 macrophages, we 
observed no differences in the ratio between CKO and WT mice (Fig. 10B). 
Besides macrophages, we decided to interrogate other types of adipose-resident 
immune cells that could express ST2 as well. In the absence of Blimp-1+ Tregs, there 
was no difference in the percentage of adipose-resident ST2+ non-Treg leukocytes (Fig. 
10A). It was previously shown that IL-33 promotes IL-2 secretion by dendritic cells, and 
that this facilitates expansion of ST2+ Tregs147. In addition, DCs have been shown to 
directly suppress VAT inflammation and assist in metabolic homeostasis148. However, 
when we examined the F4/80- CD11bmed CD11c+ dendritic cell compartment, we saw no 
changes between Blimp-1 CKO and WT mice (Fig. 9C). In addition, different B cell 
subsets have been implicated in either promotion or protection from insulin resistance149, 
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and IL-10 producing ST2+ B cells have been identified during gut inflammation150. When 
we examined total B220+ B cells in our mice, we did not see any changes in their 
frequency between WT and CKO mice (Fig. 9C).  
Interestingly, we did observe fewer adipose-resident NK cells and a higher 
percentage of CD8 T cells (Fig. 9D-E). The decrease in NK cells was promising as they 
are known to be pro-inflammatory and enhance insulin resistance when present151.  In 
contrast, the increase in CD8 T cells was concerning at first as they are believed to 
contribute towards insulin resistance152. However, our preliminary data indicate that in the 
absence of Blimp-1+ Tregs, adipose-resident CD8 T cells express more PD-1 exhaustion 
marker. Thus, additional studies are required to determine whether these cells are 
actually functional. 
Hence, although there were a few changes in the adipose immune cell 
compartment, these differences did not provide a clear and convincing argument for the 
improved metabolic outcomes in CKO mice. 
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Figure 13. Changes in the VAT immune cell landscape with loss of Blimp-1+ Tregs.  
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 18-20 weeks prior to global immunophenotyping of the visceral adipose 
tissue by flow cytomtery. (A) Frequency of leukocytes, and ST2+ leukocytes in the presence and absence 
of Blimp-1+ Tregs. (B) Total frequency of F4/80+ CD11b+ macrophages as a percentage of innate immune 
cells. Frequency of CD11c+ M1 macrophage, CD206+ M2 macrophage, and CD11c+ CD206+ 
heterogeneous macrophage populations as a percentage of the total macrophage population. (C) 
Frequnecy of B220+ B cells, and F4/80- CD11bmed CD11c+ dendritic cells. (D-E) Representative flow plots 
and quantification of NK cells and CD8 T cells in spleen and adipose. Data are presented as means ± SEM 
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and are pooled from at least 2 independent experiments with n=5-14. Each dot represents one mouse. 
Unpaired Student’s t-test was utilized (n.s.= not significant). 
2.3.5 The role of Blimp-1+ Tregs in thermogenesis 
A recent study by Rajbhandari et al. (2018) found that Il10 null mice were protected 
from age-associated and HFD- induced obesity, and that they had improved glucose 
tolerance compared to WT mice153. In addition, they determined that inguinal white 
adipocytes transduced in vitro with shIL-10R adenovirus expressed less thermogenesis 
genes such as Ucp1, Cox8b, and Cidea44, and that administration of IL-10R anti-sense 
oligonucleotide-specific to adipose tissue could lead to increased expression of 
thermogenic genes Ucp1, Cidea, Cox8b and Otop1 in the iWAT, and decreased fat 
mass153. Hence, we hypothesized that decreased IL-10 production by Blimp-1-deficient 
Tregs may lead to increased thermogenesis and protection from obesity. 
We first tested this hypothesis by examining the brown and white adipose depots 
of mice on SFD. Utilizing real-time PCR, we found that Treg-specific Prdm1 deletion had 
no effects on thermogenic genes (Ucp1, Prdm16, Cidea, Dio2) in the IAT (Fig. 11A). We 
also utilized western blotting to measure UCP1 and PRDM16. Although there was a slight 
increase in protein expression, the differences were not statistically significant (Fig. 11B). 
In addition to thermogenesis markers, we also measured a number of genes 
characteristic of white adipose tissue (AdipoQ, Fabp4, Plin2, Pparg), however expression 
of these genes remained stable (Fig 11A). We next examined the VAT by real-time PCR. 
Unlike the inguinal adipose tissue, we found that loss of Blimp-1+ Tregs led to increased 
expression of Ucp1 in this tissue (Fig. 11A). Finally, we examined the BAT, but did not 
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detect any changes in thermogenesis genes or WAT-associated genes (Fig. 11A). 
However, in vitro treatment of differentiated beige cell lines with IL-10 demonstrated that 
this cytokine is able to directly suppress Ucp1 (Fig. 11C). In addition to analyzing 
thermogenic genes and proteins, we also measured energy expenditure by these mice 
over the course of 48hrs, as well as their rectal temperatures but we did not detect any 
changes (Fig. 11D-E). Taken together, these data suggested that in SFD mice, Blimp-1 
Treg deficiency leads to limited, localized adipocyte beiging in the VAT only. 
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Figure 14. Loss of Blimp-1+ Tregs has limited effect on thermogenesis in lean mice.  
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 20% standard fat diet (SFD) for 18-20 weeks prior to analysis. (A) Inguinal white adipose tissue (iWAT), 
visceral adipose tissue (VAT) and brown adipose tissue (BAT) were isolated and analyzed via real-time 
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PCR. (B) Western blots of total iWAT, and quantification of bands normalized to beta-actin (A.U.= arbitrary 
units). Each lane represents one biological replicate. (C) Real-time PCR of in vitro differentiated beige 
adipocyte cell lines treated for 48 hours with recombinant IL-10. Each dot represents a technical replicate 
and are representative of two independent experiments. (D) Mice were placed in Promethion Multiplexed 
Metabolic Cage System for 48hrs, and energy expenditure (EE) was recorded during 12hr light/dark cycles. 
(E) Rectal temperature. Data from (A), (D) and (E) are presented as means ± SEM, and are from pooled 
from 2-3 independent experiments with n=3-16 mice, where each dot represents one mouse. Unpaired 
Student’s t-test or one-way ANOVA was utilized. 
 
We next examined how loss of Blimp-1+ Tregs affects thermogenesis in HFD mice. 
We observed that CKO mice had increased expression of Ucp1, Prdm16 and Dio2 in IAT, 
as well as increased expression of Dio2 in BAT (Fig. 12A). In addition, we observed a 
substantial increase in UCP1 protein expression in CKO mice compared to WT mice (Fig. 
12B). Similarly to SFD mice, we did not observe any changes in energy expenditure or 
rectal temperature (Fig. 12C-D). Taken together, we concluded that loss of Blimp-1+ 
Tregs increased thermogenesis and adipocyte beiging in HFD mice. 
 65 
 
Figure 15. Loss of Blimp-1+ Tregs leads to increased thermogenesis in obese mice.  
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 18-20 weeks prior to analysis. (A) Inguinal white adipose tissue (iWAT), 
visceral adipose tissue (VAT) and brown adipose tissue (BAT) were isolated and analyzed via real-time 
PCR. (B) Western blot of total iWAT, and quantification of bands normalized to beta-actin (A.U.= arbitrary 
units). Each lane represents one biological replicate. (C) Real-time PCR of in vitro differentiated beige 
adipocyte cell lines treated for 48 hours with recombinant IL-10. Each dot represents a technical replicate 
and are representative of two independent experiments. (D) Mice were placed in Promethion Multiplexed 
Metabolic Cage System for 48hrs, and energy expenditure (EE) was recorded during 12hr light/dark cycles. 
(E) Rectal temperature. Data are presented as means ± SEM, and are from pooled from 2-3 independent 
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experiments with n=4-12, where each dot represents one mouse. Unpaired Student’s t-test or one-way 
ANOVA was utilized. 
 
One question that remained was whether the changes in insulin sensitivity and 
thermogenesis in obese mice were directly caused by loss of Blimp-1+ Tregs, or if they 
were secondary to weight loss. Thus, to address this question, we decided to analyze 
Prdm1f/f Foxp3-YFP-Cre+ mice after they were on HFD for only 3 weeks. This was the 
timepoint that we previously identified that after which body weight begins to diverge (Fig. 
8). As expected, Blimp-1 CKO mice exhibited no change in body weight, and lean and fat 
mass remained the same (Fig. 13A, 13G). Blimp-1 Treg deficient short-term HFD mice 
had no changes in fasting insulin, but decreased fasting glucose, leading to overall 
decreased insulin resistance (Fig. 13B-D). However, when a glucose tolerance test was 
performed, there were no differences in circulating insulin or glucose between the two 
experimental groups (Fig. 13E-F). Metabolic chamber analyses over the course of 48hrs 
found no differences in feeding behavior or activity level (Fig. 13H-I). There was a trend 
towards elevated glucose oxidation in the CKO group during the light cycle, although it 
was not statistically significant (Fig 13J). 
 67 
 
Figure 16. Loss of Blimp-1+ Tregs protects against insulin resistance in short-term HFD mice. 
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 3 weeks prior to metabolic analysis. (A) Body weight of 11-week old HFD-
fed WT and CKO mice. (B-C) Fasting plasma insulin and glucose levels in WT and CKO mice. (D) Fasting 
insulin resistance as measured by homeostatic model assessment of insulin resistance (HOMA-IR) in WT 
and CKO mice. (E-F) Intraperitoneal glucose tolerance test. Plasma insulin and blood glucose levels over 
time post-glucose injection. Bar graphs represent area under the curve (AUC). (G) Body composition as 
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measured by EchoMRI. (H-J) Mice were placed in Promethion Multiplexed Metabolic Cage System for 
48hrs and measurements recorded in 5-minute increments during 12hr light/dark cycles. (H) Food intake 
in grams (g) per kilogram (kg) lean mass (LM). (I) Total activity in meters (m) over 48 hours. (J) Respiratory 
exchange ratio (RER) where 0.7 indicates fatty acid oxidation and 1.0 indicates glucose oxidation. Data are 
presented as means ± SEM and are pooled from 2 independent experiments with n=5 per group. Each dot 
represents one mouse. Unpaired Student’s t-test or one-way ANOVA was used. 
 
Analyses of Tregs within the various adipose depots found that Blimp-1 CKO mice 
had increased total Tregs in the VAT and BAT (Fig. 14A). In addition, loss of Blimp-1 led 
to numerous changes in the signature of VAT, BAT and IAT Tregs (Fig. 14A), and IL-10 
production was perturbed in Blimp-1 deficient VAT, IAT, and lymphoid Tregs (Fig. 14B). 
Finally, when we examined thermogenic and white adipose tissue-associated 
genes, we found that thermogenic genes such as Prdm16, Cidea and Dio2 were up-
regulated in IAT and VAT (Fig. 15A-B). We detected no changes in the BAT (Fig. 15C). 
Systemically, the total energy expenditure between the two groups were the same (Fig. 
15D). Thus, taken together, our short-term HFD data supported the notion that Blimp-1 
deficient Tregs can directly protect mice from metabolic dysfunction and induce adipocyte 




Figure 17. Blimp-1-deficient Tregs from short-term HFD mice exhibit altered adipose Treg signature.   
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 3 weeks prior to Treg analysis by flow cytometry. (A) Frequency of CD4+ 
Foxp3+ Tregs and adipose Treg markers on the cells. (B) Total adipose and secondary lymphoid organ 
stromal vascular fractions were stimulated ex vivo for 5 hours with PMA and ionomycin. Quantification of 
IL-10 producing Tregs. Cells gated off CD4+ Foxp3+ T cells. 
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Figure 18. Loss of Blimp-1+ Tregs leads to increased adipocyte beiging in short-term HFD mice. 
Eight-week-old Prdm1f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 3 weeks prior to analysis. A) Inguinal white adipose tissue (iWAT), (B) 
visceral adipose tissue (VAT), and (C) brown adipose tissue (BAT) were isolated and analyzed via real-
time PCR. (D) Mice were placed in Promethion Multiplexed Metabolic Cage System for 48hrs, and energy 
expenditure (EE) was recorded during 12hr light/dark cycles. 
 
Next, to confirm that increased thermogenesis in Blimp-1 deficient mice was 
mediated by IL-10, we generated Il10f/f Foxp3-YFP-Cre+ mice lacking IL-10 on all Tregs. 
Similarly, to what was observed in the Blimp-1 CKO mice, these mice weighed less Fig. 
16A). Upon examination of their gross morphology, their inguinal and visceral fat pads 
appeared smaller, and their livers were darker in color suggesting less hepatic steatosis 
(Fig. 16G). EchoMRI analysis confirmed that the difference in body weight between the 
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CKO and WT mice were a result of reduced fat mass and not lean mass (Fig. 16I). 
Changes in body weight and composition were not attributable to nutrient malabsorption 
as histological analyses of the colon indicated no changes in inflammation or colon length 
(Fig. 16H).  
Metabolically, the CKO mice fared better than their WT counterparts. CKO mice 
had lower fasting insulin and glucose levels, and reduced insulin resistance (Fig. 16B-D). 
In addition, there was less circulating insulin and glucose in the blood during glucose 
tolerance testing (Fig. 16E-F). When the mice were placed in metabolic chambers for 
48hrs, there were no changes in feeding behavior or activity between the two groups (Fig. 
16J-K). However, during the light cycle, the CKO mice had increased RER indicating 
greater glucose oxidation (Fig. 16L). Finally, thermogenic markers were compared 
between WT and IL-10 Treg deficient mice. CKO mice had increased expression of 
thermogenic markers such as Ucp1, Prdm16, Cidea and Dio2 at the gene and protein 
level in the inguinal and visceral white adipose tissue (Fig. 16M, Fig.17A-B). 
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Figure 19. Loss of IL-10+ Tregs protects mice from diet-induced obesity. 
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Eight-week-old Il10f/f Foxp3-YFP-Cre+ (CKO) or wild-type littermate control (WT) male mice were placed 
on 60% high fat diet (HFD) for 18-20 weeks prior to metabolic analysis. (A) Body weight of 26-28-week old 
HFD-fed WT and CKO mice. (B-C) Fasting plasma insulin and glucose levels in WT and CKO mice. (D) 
Fasting insulin resistance as measured by homeostatic model assessment of insulin resistance (HOMA-IR) 
in WT and CKO mice. (E-F) Intraperitoneal glucose tolerance test. Plasma insulin and blood glucose levels 
over time post-glucose injection. Bar graphs represent area under the curve (AUC). (G) Gross appearance, 
inguinal WAT (iWAT), epididymal visceral WAT (VAT) and livers. (H) Top: Photographs and quantification 
of the colon length in WT and CKO mice after 18-20 weeks on HFD. Bottom: H&E stain of colon cross-
section. (I) Body composition as measured by EchoMRI. (J-L) Mice were placed in Promethion Multiplexed 
Metabolic Cage System for 48hrs and measurements recorded in 5-minute increments during 12hr 
light/dark cycles. (J) Food intake in grams (g) per kilogram (kg) lean mass (LM). (K) Total activity in meters 
(m) over 48 hours. (L) Respiratory exchange ratio (RER) where 0.7 indicates fatty acid oxidation and 1.0 
indicates glucose oxidation. (M) Western blot of total iWAT, and quantification of bands normalized to beta-
actin (A.U.= arbitrary units). Each lane represents one biological replicate. Data are presented as means ± 
SEM and are pooled from 3 independent experiments with n=3-8 mice per group. Each dot represents one 
mouse. Unpaired Student’s t-test or one-way ANOVA was used (*=P value <0.05). 
 
Figure 20. Loss of IL-10+ Tregs leads to increased thermogensis and beiging in obese mice. 
8-week-old male Foxp3-YFP-Cre+ (WT) and IL-10f/f  Foxp3-YFP-Cre+ mice (IL-10 CKO) were placed on 
60% high fat diet (HFD) for 18-20 weeks prior to real-time PCR analysis. Bar graphs showing relative mRNA 
expression from total (A) iWAT and (B) VAT. Values were normalized to beta-actin. Data are presented as 
means ± s.e.m. for n = 3 mice per group. An unpaired Student’s t-test was performed to determine 
significance and the P values are indicated on the graphs. 
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2.3.6 The Role of Tregs and IL-10 during human obesity 
Finally, we attempted to check whether a correlation existed between Tregs and 
human obesity. To do so, we utilized publicly available data from the Metabolic Syndrome 
in Men (METSIM) study. This cross-sectional population-based longitudinal study utilized 
microarrays to analyze gene expression in abdominal subcutaneous adipose tissue from 
randomly selected Finnish men ages 45-70yrs old154. Alongside, these data, clinical 
features associated with obesity were also collected154. Using these data, we correlated 
BMI to Foxp3 expression by T cells and found that there was a negative correlation 
between the two (Fig. 17A). In addition, subjects with increased BMI had higher levels of 
IL-10r and total IL-10 (Fig. 17B-C). Of the IL-10 being expressed, the portion due to 
adipose Tregs also positively correlated with BMI (Fig. 17D). Combining these data with 
the previously described pre-clinical findings supports further investigation into the role of 
adipose Treg-derived IL-10 in maintaining metabolic homeostasis in humans, and 
provides a possible therapeutic target in restoring insulin sensitivity during obesity.  
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Figure 21. Clinical correlation of IL-10+ Tregs to increased body mass index. 
Publicly available data from the Metabolic Syndrome in Men (METSIM) study were analyzed to identify 
possible correlations between Treg IL-10 and obesity. This cross-sectional population-based longitudinal 
study utilized microarrays to analyze gene expression in abdominal subcutaneous adipose tissue from 
randomly selected Finnish men ages 45-70yrs old. 
2.4 Discussion 
The role of Tregs in peripheral tissues has been extensively explored over the past 
decade, with most publications delineating a role for these cells in suppressing local 
inflammation and maintaining tissue homeostasis23, 79, 80, 85, 91, 92, 96, 97, 100, 127. However, 
recent publications have revealed that the function of peripheral Tregs is more complex 
than initially reported and is tissue and context dependent. For example, aTregs have 
been shown to be pathogenic in age-associated obesity93, 155. In addition, WT female 
mice, which have reduced aTreg frequency and IL-10 secretion, are protected from 
glucose intolerance and fat gain, relative to age-matched male mice, although whether 
glucose tolerance and fat reduction in female mice are driven through an IL-10–deficient 
aTreg axis has not yet been established80. Similarly, the role of Blimp-1 in the immune 
system is highly context dependent and tissue specific. For example, it was recently 
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shown that Blimp-1 is an unexpected positive regulator of Th2 responses in the lung, 
facilitated through an IL-10/STAT3 axis156.  
Treg-secreted IL-10 is known to suppress inflammatory immune cells and for the 
maintenance of tissue homeostasis, particularly at barrier surfaces157, 158. In this present 
study, we show that Treg IL-10 is also critical for suppressing adipocyte beiging in male 
mice. Loss of IL-10 expression by Tregs resulted in mice that were protected from DIO 
and showed improved insulin sensitivity. Mechanistically, Treg-intrinsic loss of Blimp-1 
led to reduced IL-10 production, resulting in increased expression of PRDM16 and UCP1 
by adipocytes, proteins that are critical for upregulation of the beiging program153, 159, 160. 
One puzzling aspect of our findings was that whole-body energy expenditure did not 
increase with loss of IL-10 or Blimp-1 by Tregs, despite an increase in beige gene 
expression in the visceral and inguinal adipose tissue depots. IL-10 is, however, secreted 
by other B and T cell populations in the adipose tissue133, and it may be that IL-10 from 
these additional cells counters an increase in whole-body expenditure in our model.  
It is well established that IL-10 secretion by Tregs is essential for preventing gut 
inflammation and colitis116, 119, 125. However, in our system, we found no evidence of Treg-
specific deletion of IL-10 or Blimp-1 resulting in colitis and influencing the weight loss 
phenotype we observed. Mice on HFD gained weight, albeit at a slower rate than their 
WT counterparts. Possible factors for these distinctions may include the animal’s 
microbiota and the variety of chow used across studies, as well as the age and subtle 
differences in the background of the mice. We were encouraged to see our phenotype 
was consistent with that of the recently published germline IL-10–deficient animals153 and 
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that colitis was likely not a factor underlying the weight loss and IR we observed in the 
Treg-specific IL-10– and Blimp-1–deficient animals.  
Finally, we consider our findings in the context of previously reported aTreg 
functions in DIO. Prior data have shown a clear correlation between reduced aTreg 
frequency and increased body mass and that temporal ablation of Tregs increases IR and 
adipose tissue inflammation23. In our study, we report similar reductions in aTreg 
frequency in both WT and Blimp-1–deficient mice when these animals were placed on 
HFD. However, our data uniquely demonstrated that disruption of aTreg IL-10 secretion 
can reduce IR. Excluding IL-10, Tregs can secrete a number of other anti-inflammatory 
soluble mediators, including TGF-β, IL-35, amphiregulin, and methionine-enkephalin161-
164. Hence, our findings suggest that the sum total of these Treg-derived mediators may 
need to be considered to accurately define how Tregs dictate whole-body metabolism 
and adipose tissue inflammation. 
Together, our findings reveal that IL-10 secretion by Tregs is not limited solely to 
suppression of effector and autoreactive immune cells157, 158, but rather that Tregs release 
IL-10 to promote the suppression of the beige gene program in adipocytes. Ultimately, 
these data have implications for the role of the immune cell-adipocyte axis in mediating 
systemic metabolism and protection from DIO. 
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Figure 22. Tregs facilitate obesity and insulin resistance through a Blimp-1/IL-10 axis. 
During diet-induced obesity, Blimp-1+ Tregs secrete IL-10 to suppress Ucp1 thermogenesis gene 
expression in white adipose tissue.  In the absence of Blimp-1+ Tregs, reduced IL-10 signaling leads to 
Ucp1 up-regulation, increased adipocyte beiging, improved insulin sensitivity and limited weight gain. 
2.5 Future Directions 
In this project, we determined that Tregs facilitate obesity through a Blimp-1/IL-10 
axis.  Blimp-1 positively regulated IL-10 secretion in adipose Tregs, and IL-10 acted on 
beige adipocytes to suppress thermogenesis.  In HFD mice, this resulted in increased 
weight gain, insulin resistance and glucose intolerance compared to mice lacking Blimp-
1+ Tregs.  Traditionally, Tregs have been viewed as critical for preserving insulin 
sensitivity and glucose tolerance89-91.  However, in our study, we found that the Blimp-1+ 
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Tregs can be detrimental during obesity.  As described earlier in Chapter 1: Introduction, 
insulin sensitivity and thermogenesis are regulated by a multilateral network involving 
immune cells, adipocytes, and other endocrine organs (e.g. pancreas, liver, skeletal 
muscle) that communicate with one another at both the local and systemic level through 
secretory factors (e.g. cytokines, adipokines) and direct contact.  Therefore, in order to 
understand the impact and significance of Blimp-1+ Tregs, these cells must be studied in 
relation to the other players that shape adipose immunobiology and metabolism. 
2.5.1 Treg-intrinsic role of Blimp-1 
2.5.1.1 Role of Blimp-1 in Treg activation, differentiation and function 
In our project, we observed variable distributions of VAT, IAT and BAT Tregs in 
Prdm1 f/f Foxp3-YFP-Cre+ mice (CKO) versus wild-type (WT) mice.  Previous studies 
have shown that Blimp-1 is required for peripheral Treg homeostasis, and that loss of 
Blimp-1 leads to increased Tregs in organs such as the intestines and lungs113, 116, 118.  
This was attributable to increased Treg proliferation and decreased cell death116.  In 
addition, it has been suggested that VAT Tregs undergo a 2-step differentiation process, 
in which thymic Tregs first traffic to the spleen, and then PPARglo Blimp-1lo Tregs that 
become antigen-experienced proceed to migrate into the VAT where they acquire their 
full aTreg signature100.  In our study, loss of Blimp-1 led to decreased VAT Treg frequency 
in SFD mice, and increased BAT Treg frequency in HFD mice.  In addition, in both lean 
and obese mice, loss of Blimp-1 led to increased iLN and splenic Tregs.  The higher 
frequency of secondary lymphoid organ Tregs suggests that they may be accumulating 
in these organs as a result of defective trafficking.  Indeed, in our VAT Tregs, we saw that 
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loss of Blimp-1 led to decreased CCR2 expression.  Our observations are in line with 
previously published research showing that Blimp-1 deficient VAT Tregs have decreased 
CCR2 and increased CCR7 (a secondary lymphoid organ targeting chemokine 
receptor)80.  However, cell proliferation and apoptosis studies need to be performed to 
determine whether cellular turnover is affected. 
In addition, Blimp-1 has been shown to play differing roles in peripheral effector 
Treg activation in inflamed versus non-inflamed tissue.  In one study involving influenza 
infection,  loss of Blimp-1 led to decreased ICOS+ lung Tregs113.  However, in a different 
study under homeostatic conditions, loss of Blimp-1 led to increased ICOS+ Tregs across 
multiple peripheral tissues116.  Obese adipose tissues experience chronic low-grade 
inflammation, and the degree of inflammation differs between VAT, scAT, and BAT49-51.  
Therefore, it would be interesting to examine whether the activation status differs between 
Blimp-1+ and Blimp-1- Tregs in the various adipose depots using our Blimp-1 YFP 
reporter mice.  In particular, we could measure the expression of co-stimulatory molecules 
such as CD28, ICOS, OX40, 4-1BB, GITR and TNFR2 on adipose-resident Tregs165.   
As mentioned earlier, in addition to IL-10, Tregs can secrete TGF-β, IL-35, 
amphiregulin, methionine-enkephalin, Jagged 1 (Notch ligand) and cleave ATP to 
adenosine161-164, 166-168.  Although in our study we observed that loss of Blimp-1+ Tregs 
helped maintain insulin sensitivity, other studies involving total loss of Tregs have found 
that it exacerbated insulin resistance23, 31, 89-91.  Therefore, we should determine whether 
Blimp-1 deletion affects Treg function and systemic metabolism in an IL-10 independent 
manner.  For example, IL-35 secreted from ST2+ Tregs have been shown to inhibit 
gamma-delta T cells in the lung during allergen exposure169, and gamma-delta T cells 
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have been shown to support age-associated accumulation of VAT Tregs and promote 
cold-induced thermogenesis in the scAT and BAT170.  In addition, amphiregulin can 
positively regulate PGC1a in the VAT171, and PGC1a maintains metabolic homeostasis 
by regulating gluconeogenesis, fatty acid oxidation and preventing oxidative damage in 
the liver172-174, and also by inducing scAT beiging175.  Furthermore, administration of 
methionine-enkephalin to HFD mice has been shown to increase scAT beiging and 
decrease weight gain, insulin resistance, glucose intolerance and hepatic steatosis176.  
Finally, adenosine has been shown to induce lipolysis and thermogenesis in scAT and 
BAT177. 
Besides secretory factors, Tregs can use cell surface molecules such as CTLA4, 
TIGIT, TRAIL and PD-1 to directly suppress dendritic cells and conventional T cells178.  In 
addition, it has been shown that although LAG3 does not affect Treg immunosuppressive 
capacity on a cellular level, it negatively regulates Treg maintenance and proliferation 
pathways, and hence loss of LAG3 leads to increased immunosuppressive capacity at 
the population level in pancreatic intra-islet Tregs during autoimmune Type 1 diabetes179.  
It will be interesting to investigate whether Blimp-1 regulates any of these inhibitory 
proteins in Tregs. 
2.5.1.2 Blimp-1 mediated transcriptional regulation 
In addition to determining whether or not Blimp-1 has an effect on non-IL10 related 
Treg function, it is important to identify the signaling networks that mediate Blimp-1 
dependent changes in aTreg differentiation and function.  For instance, researchers have 
previously observed that ß-adrenergic signaling induces naïve CD4 T cells in the BAT to 
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become Tregs through STAT6/PTEN signaling94.  In VAT Tregs, TCR signaling induces 
the transcription factors BATF and IRF4 to directly bind and upregulate expression of 
Pparg and Il1rl1 to promote cell proliferation and maintain VAT Treg identity92.  As 
mentioned earlier, IRF4/Blimp-1 interaction is involved in generating lung effector Tregs 
during influenza infection113.  It may be possible that a similar interaction occurs in aTregs 
as well.  Besides these pathways, it has been shown that Bcl6 and Blimp-1 are reciprocal 
regulators of Tfh differentiation during LCMV infection180, as well as in ST2+ Treg 
development during allergic asthma inflammation181, indicative of a role for Bcl6. 
2.5.2 Blimp-1+ Tregs in adipose tissue inflammation and metabolic regulation 
during obesity 
2.5.2.1 Drivers of Blimp-1 expression in adipose Tregs during obesity 
Besides examining the Treg-intrinsic role of Blimp-1, we should also consider how 
Blimp-1+ Tregs function within the adipose ecosystem and how they affect metabolic 
outcomes.  As Blimp-1 expression in Tregs appears to be detrimental during diet-induced 
obesity, the first question we should address is what drives Blimp-1 expression in these 
cells, and how can we limit it?  It has previously been established that Blimp-1 expression 
is driven by T cell receptor activation in the presence of IL-2, and that its expression can 
be further enhanced by cytokines such as IL-12, IL-4 and IL-6113. 
During excessive caloric intake, fats are stored as triglycerides in the adipose 
tissue13.  However, when adipocytes become too hypertrophic, they risk the possibility of 
eventually rupturing and releasing free fatty acids into the environment26-28.  In addition, 
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increased insulin resistance during obesity prevents uptake of ingested fats into cells 
resulting in increased circulating fatty acids39-41.   
It may be possible that these fatty acids serve as T cell receptor ligand and trigger 
Blimp-1 expression, or they may serve to enhance Blimp-1 expression once TCR 
stimulation occurs.  Although, it has not been shown directly that fatty acids regulate 
Blimp-1 expression in Tregs, the fact that fatty acids have been shown to regulate IL-10 
production suggests that a fatty acid/Blimp-1/IL-10 axis is possible. 
For example, one study examined the role of monounsaturated omega-9 fatty acid 
oleic acid on Tregs during multiple sclerosis182.  The researchers found that oleic acid 
was the most abundant long-chain fatty acid in the adipose tissue of their healthy donors, 
and that it was decreased in patients with multiple sclerosis (and inversely, circulating 
oleic acid was greater in patients with multiple sclerosis compared to healthy control)182.  
They also observed that circulating Tregs from multiple sclerosis patients had decreased 
IL-10 production and diminished suppressive capacity compared to their healthy 
counterparts182.  However, when Tregs sorted from the PBMCs of multiple sclerosis and 
healthy controls were cultured with oleic acid, IL-10 production increased in both groups 
and the suppressive capacity of Tregs from multiple sclerosis patients was partially 
restored182.  Mechanistically, they found that the effect of oleic acid on Treg suppressive 
capacity occurred through increased fatty acid oxidation182.  Interestingly, it has been 
shown before that Blimp-1 positively regulates Pparg80, and PPARG regulates lipid 
metabolism in VAT Tregs from male mice85.  Adding additional support to the idea that 
fatty acids may induce Blimp-1 expression in Tregs is the finding that at least in Th1 cells, 
the microbiota-derived short-chain fatty acid butyrate can activate a G-protein coupled 
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receptor 43 (GPR43)/STAT3/mTOR/Blimp-1 pathway to ultimately induce IL-10 
secretion183.  Besides these two findings, it has also been demonstrated more generally 
that ex vivo stimulation of splenic T cells from mice fed polyunsaturated omega-3 fatty 
acid-rich diet produced more IL-10 than T cells from mice fed a polyunsaturated omega-
6 fatty acid-rich diet184.  It has also been shown that CD4 T cells stimulated ex vivo in the 
presence of omega-3 fatty acid eicosapentaenoic acid secreted higher levels of IL-10, 
whereas cells stimulated in the presence of omega-3 fatty acids docosahexaenoic acid 
produced less IL-10 relative to control cells that were stimulated in the absence of fatty 
acids185.  Therefore, my initial hypothesis is that omega-3 fatty acid eicosapentaenoic, 
long-chain fatty acid oleic acid, and short-chain fatty acid butyrate can promote Blimp-1 
expression in aTregs, whereas omega-3 fatty acid docosahexaenoic acid will suppress 
Blimp-1 expression. 
 It is also possible that fatty acids may act indirectly by activating non-Treg immune 
cells that then interact with Tregs to drive Blimp-1 expression and IL-10 secretion.  For 
example, within the colon, macrophages and dendritic cells can respond to butyrate to 
produce IL-10, which in turn promotes differentiation of naïve T cells into Tregs and IL-10 
producing T (Tr1) cells186. 
It has previously been reported that in humans, saturated fat and trans-fat intake 
is positively associated with increased weight gain, whereas poly-unsaturated fatty acid 
is not187, 188.  The role of short-chain fatty acid butyrate in obesity is controversial with 
some studies demonstrating a protective role against obesity while others indicate an 
antagonistic effect189.  Finally, the monounsaturated fatty acid oleic acid has been 
previously described to be protective against obesity, metabolic syndrome and Type 2 
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Diabetes190.  It would be interesting to examine whether fatty acids differentially regulate 
Blimp-1 expression.  To analyze the effect of dietary fat composition on Blimp-1 
expression, the frequency and MFI of Blimp-1+ Tregs can be calculated in HFD mice and 
compared them to age-matched SFD control mice before their weights diverge.  
Commercially available diets for mice differ in their formulations, and they have been 
described to have different effects on obesity-associated disease pathology191.  
Therefore, in addition to the 60% HFD we utilized in this project, we can also repeat our 
experiments in mice fed 45% HFD, cafeteria diet191, or Western diet192. 
Besides investigating whether free fatty acids drive Blimp-1 expression, it would 
be of interest to further characterize the cytokine milieu within the VAT, scAT and BAT in 
lean and obese tissue via qPCR and ELISA, and test whether the cytokine milieu drives 
differential levels of Blimp-1 expression in Tregs.  A recent study by Vasanthakumar et 
al. (2020) found that IL-6 could induce Blimp-1 expression in VAT Tregs80.  In addition, 
CD4 effector T cells, T follicular helper and NKT cells secrete IL-21.  This cytokine may 
be another possible modulator of VAT Tregs, as IL-21 KO mice have been shown to have 
higher frequency of VAT Tregs193 although whether IL-21 acts directly on adipose Tregs 
remains to be determined.  VAT Tregs may also respond to insulin.  Splenic Tregs can 
express insulin receptor, and treatment of these cells with insulin leads to AKT/mTOR 
signaling resulting in decreased IL-10 production194.  Along those lines, VAT Tregs from 
hyperinsulinemic mice produce less IL-10 than VAT Tregs from lean mice194.  In addition 
to cytokines, there are adipokines and miRNAs in the adipose that have been tied to 
insulin signaling and thermogenesis15, 30, 31, 195, 196.  It may be possible that adipokines 
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such as leptin, adiponectin, IL-6, neuregulin 4, fibroblast growth factor 21, and adipocyte-
derived miRNAs have a role in Blimp-1 expression. 
Apart from fatty acids and the cytokine/adipokine milieu, hypoxia may also affect 
Blimp-1 expression in aTregs.  It has previously been shown that hypoxia can induce 
Blimp-1 expression in human and mice pancreatic cancer cells197.  During obesity, 
adipocyte hyperplasia and hypertrophy results in decreased oxygen availability32, 33, and 
this may possibly lead to increased Blimp-1 expression in Tregs.  This can be tested in 
vitro by culturing cells in a regular tissue culture incubator under decreased oxygen 
settings. 
Recently, it has been suggested that the gut microbiota can play a role in 
determining one’s susceptibility to obesity and metabolic syndrome198.  It has previously 
been shown that Blimp-1+ Tregs can play a role in suppressing inflammation within the 
small intestines119.  It would be interesting to isolate Tregs from clinical gut biopsies of 
obese and lean humans, and see whether Blimp-1 expression differs in people with 
different intestinal flora via fecal collection.  In addition, these samples could then be used 
for fecal transplants into Blimp-1 reporter mice to see if Blimp-1 expression is altered in 
Tregs. 
2.5.2.2 Effect of Blimp-1+ Tregs and IL-10 in the adipose during obesity 
In this study, we elucidated the role of Treg-derived IL-10 on adipocytes during 
obesity.  However, the adipose tissue contains other types of cells that can also respond 
to IL-10.  Like many other types of adipokines and cytokines (e.g. IL-6, adiponectin and 
leptin), IL-10 is a pleiotropic cytokine that has differing effects depending on the cellular 
source, cell type that it’s acting on, and the local microenvironment.  Therefore, to 
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accurately understand how loss of Blimp-1+ Tregs and IL-10 affects adipose inflammation 
and systemic metabolism, one must take into consideration the other types of immune 
and stromal cells that exist within the tissue. 
In addition to Tregs, lean adipose tissue in mice is populated by immune cells such 
as M2 macrophages, ILC2s, eosinophils, and Th2 cells that maintain an anti-inflammatory 
environment.  ILC2- and Th2-derived cytokines, such as IL-5 and IL-13, support the 
maintenance of eosinophils, which through secretion of IL-4 can promote M2 macrophage 
polarization21, 22.  Furthermore, adipose Tregs and a NK1.1NEG subclass of invariant 
natural killer T cells (iNKT) can secrete IL-1023, 24 10, which can further promote M2 
polarization, and also prohibit inflammatory signaling in adipocytes25.  In contrast to lean 
adipose tissue, obese adipose tissue in mice skews towards housing pro-inflammatory 
immune cells such as M1 macrophages, CD8 T cells, T helper 1 cells (Th1) and T helper 
17 cells (Th17)30.   
In this project, we showed that in the absence of Blimp-1, Tregs produce less IL-
10.  However, it has been found that macrophages, Th2 cells, and eosinophils can 
respond to as well as produce IL-10199-201, and that ILC2s can secrete IL-10202, 203.  
Therefore, in lean mice, Treg-specific Blimp-1 deletion leads to decreased IL-10 
production, but this may possibly be compensated for by other IL-10 producing cells.  This 
would be in line with our observations that the changes in thermogenesis between Blimp-
1 CKO and WT were more muted in lean mice relative to obese mice. 
As mentioned earlier, macrophages play an important role in maintaining metabolic 
homeostasis146.  In particular, IL-10 aids in M2 macrophage polarization23-25.  Thus, we 
expected that in the absence of Blimp-1+ Tregs and decreased IL-10, our Blimp-1 CKO 
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mice will display changes in their macrophage populations.  However, our data uncovered 
no differences in total macrophage frequency or the ratio of M1:M2 macrophages 
between Blimp-1 CKO and WT mice. However, we analyzed our cells using traditional 
macrophage markers F4/80, CD11c and CD206.  In the future, it may be beneficial to 
include additional macrophage markers in our analyses to further sub-categorize these 
cells.  For example, we can use M1 macrophage markers such as iNOS and Mcp-1, and 
M2 macrophage markers such as Arg1 and CD204142.  Based off recent findings, it is now 
apparent that multiple macrophage subpopulations exist within the adipose tissue, and 
that their phenotypes change according to diet75.  Therefore, utilizing single-cell RNA seq 
may yield clearer information on how the absence of Blimp-1+ Tregs may affect this 
heterogenous population.  It may also be possible that Blimp-1+ Tregs affect their ability 
to produce TNFa, IL-1b, IL-6 or IL-10.  Changes in cytokine production may be detected 
by LPS- or IL-4/IL-13 stimulating the adipose stromal vascular fraction ex vivo and 
analyzing cytokine production by flow. 
Although there were no observable differences in macrophage frequency utilizing 
our current analysis strategy, surprisingly we saw that VAT CD8 T cells were increased 
in Blimp-1 CKO mice compared to WT controls.  Previous studies have shown that CD8 
T cells can cause insulin resistance and suppress BAT thermogenesis204, 205.  At first 
glance, these details would suggest that the increase in CD8 T cells ran contrary to our 
working hypothesis of increased thermogenesis and improved insulin sensitivity in CKO 
mice compared to WT controls.  However, it may be possible that these CD8 T cells are 
regulatory CD8 T cells, or given that they are in a chronically inflamed environment, we 
cannot rule out the possibility that they may be exhausted CD8 T cells.  It has also been 
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previously demonstrated that IL-10 can enhance CD8 T cell function during gastric 
cancer206.  Therefore, perhaps loss of Blimp-1+ Tregs leads to less IL-10, and 
dysfunctional CD8 T cells that have decreased capacity to suppress thermogenesis.  
Indeed, our lab has preliminary data suggesting that Blimp-1 deficient aTregs express 
more PD-1 (data not shown).  We are currently performing extensive phenotyping of VAT, 
IAT and BAT CD8 T cells in our Blimp-1 CKO mice to see whether or not this is the case. 
Although in our study, we examined a number of different immune cell subsets, 
four populations that we did not quantify were eosinophils, ILC2s, iNKT and regulatory B 
cells.  ILC2 and eosinophils help promote thermogenesis, insulin sensitivity and glucose 
tolerance56, 61.  IL-10 producing iNKT cells are enriched in lean scAT, and loss of iNKTs 
during DIO leads to increased insulin resistance24, 207, 208.  In addition, in vivo iNKT 
activation by aGalCer or GLP1 peptide injection can increase scAT beiging209.  Besides 
iNKT cells, loss of IL-10 producing regulatory B cells has also been shown to increase 
insulin resistance210. Given their connection to thermogenesis, insulin sensitivity and 
glucose tolerance, it would be interesting to study whether loss of Blimp-1+ Tregs affects 
any of these populations. 
2.5.2.3 Effect of Blimp-1+ Tregs and IL-10 on systemic metabolism during obesity 
In this study, the Prdm1f/f Foxp3-YFP-Cre+ mice and the Il10f/f Foxp3-YFP-Cre+ 
mice that were utilized affected all Tregs within the body.  Other organs such as the liver, 
pancreas and skeletal muscle play critical roles in maintaining insulin sensitivity and 
glucose tolerance, and Tregs are present within these tissues as well.  For example, one 
study found that non-alcoholic steatohepatitis patients have a higher hepatic Th17:resting 
Treg ratio compared to non-alcoholic fatty liver disease patients211, and similarly in mice, 
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non-alcoholic steatohepatitis mice had an increased Rorgt:Foxp3 hepatic mRNA ratio 
compared to normal diet mice212 suggesting that a balance of Th17 and Tregs must be 
maintained to prevent abnormal liver pathology during obesity.  To date, a role for 
pancreatic Tregs during DIO has not yet been described.  However, it is worth noting that 
in Type 1 autoimmune diabetes NOD mice, CXCR3+ and ICOS+ pancreatic Tregs have 
been shown to suppress local inflammation as well as delay the onset and incidence of 
disease213, 214.  Finally, skeletal muscle Tregs are decreased in HFD mice compared to 
standard chow mice215.  Treatment of obese mice with resveratrol (an anti-inflammatory 
polyphenol) has been shown to be protective against obesity and correlated with 
increased M2 polarization and Treg infiltration into the skeletal muscle216.  Therefore, the 
effect of Blimp-1 deletion on hepatic, pancreatic and skeletal muscle Tregs may be worth 
further examination. 
Besides looking at inflammatory changes in the liver, pancreas and skeletal 
muscle, it would be interesting to examine whether Blimp-1+ Tregs affect metabolic 
processes within these organs.  In our project, Blimp-1 CKO and IL-10 CKO mice 
exhibited improved insulin sensitivity, which is critical for regulating gluconeogenesis, 
glycogenolysis, de novo lipid synthesis in the liver, triglyceride synthesis and lipolysis.  
What’s more, if we find that loss of Blimp-1+ Tregs results in decreased IL-10 in the blood, 
we cannot rule out the possibility that Treg IL-10 from one tissue may act distally on 
another organ to help maintain metabolic homeostasis.  Although a role for IL-10 in the 
pancreas has not been described, it is known that IL-6 (another cytokine that signals 
through STAT3) enhances insulin secretion by pancreatic beta cells217.  In addition, IL-10 
has been shown to help maintain insulin sensitivity in skeletal muscle and prevent 
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macrophage infiltration and reduce IL-6 and TNFa within the muscle218.  Although these 
findings by other labs can at first appear to conflict with our findings that loss of IL-10 
improved insulin sensitivity, we must not forget to consider IL-10’s effect on 
thermogenesis and how that affects systemic metabolism.   
During BAT thermogenesis, BAT macrophages are in direct contact with BAT-
innervating neurons and a plexin-semaforin signaling axis modulates norepinephrine 
activated thermogenesis54.  It would be interesting to see whether loss of Blimp-1+ Tregs 
and its associated IL-10 has any effect on the frequency or phenotype of BAT 
macrophages as well as the concentration of BAT-innervating neurons, or their activity.   
In addition to the BAT, loss of Blimp-1+ Tregs and IL-10 in the scAT may affect the 
local immune cell populations that ultimately affect thermogenesis.  As mentioned earlier, 
M2 macrophages, eosinophils and ILC2s can induce scAT beiging57-61.  Furthermore, 
macrophages and eosinophils can respond to as well as produce IL-10199-201, and ILC2s 
can secrete IL-10202, 203.  Therefore, it is possible that reduced IL-10 availability in Blimp-
1 CKO mice might affect these cells’ ability to carry out thermogenesis. 
Finally, in our study, we performed thermogenic analysis on mice that were housed 
at 22°C.  In both our short-term and long-term HFD mice, there were noticeable 
differences in IAT thermogenesis between our CKO and WT mice.  However, with regard 
to BAT thermogenesis, we only observed an increase in one thermogenic gene in our 
CKO compared to WT.  In addition, loss of Blimp-1+ Tregs had no effect on energy 
expenditure in both the short-term and long-term HFD mice.  Moving forward, it may be 
worth conducting adaptive or ß-adrenergic studies to see whether a stronger phenotype 
is induced when the mice are placed under greater physiological stress.  Furthermore, for 
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mice, the range for thermoneutrality is ~29-33ºC depending on the time of the day219.  
Performing experiments on mice raised at warmer temperatures may yield data that is 
more physiologically relevant to humans than performing pre-clinical studies in mice that 
are housed at the current temperature. 
2.5.3 Therapeutic potential of Blimp-1+ Tregs during obesity 
Some individuals tend to gain weight more readily than others.  In order to 
determine how genetics may play a possible role, it may be worth isolating Tregs from 
the omental adipose of age- and sex-matched obese and healthy individuals to see 
whether single nucleotide polymorphisms within the Blimp-1 locus can be identified and 
utilized as a marker for reduced susceptibility towards obesity.  Besides searching for 
correlations, we can also raise obese Prdm1f/f Foxp3eGFP-Cre-ERT2 mice, then induce Blimp-
1 deletion in Tregs with tamoxifen to see whether obesity can be reversed if Blimp-1+ 
Tregs are selectively removed. 
2.5.4 Conclusion 
In summary, loss of Treg-derived IL-10 may have protective or detrimental effects 
on metabolism depending on whether individuals are lean or obese.  As a result, we 
cannot assume that findings in SFD mice will be replicable in HFD mice, and thus we 
must be diligent in performing experiments in each of the diet models before any 
conclusions are made.  To address IL-10’s possible pleiotropic effect during diet-induced 
obesity, immune cell and metabolic phenotyping should occur in both Blimp-1f/f Foxp3-
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Cre+ and Il10f/f Foxp3-Cre+ mice both pre- and post- HFD diet intervention, and at various 
stages of obesity to account for differences in the adipose immune cell landscape.  
Adipose Tregs do not exist in a vacuum.  In order to have a true grasp on the role 
of these cells during diet-induced obesity, it is critical that we integrate our Blimp-1+ aTreg 
findings with the rest of the adipose microenvironment as well as with the systemic 
metabolic changes that are occurring during obesity.  Traditionally, immunologists have 
examined Tregs in isolation and have attempted to make a direct link to insulin sensitivity, 
glucose tolerance and thermogenesis.  However, based off the findings in this project 
indicating the antagonistic effects of Blimp-1+ Tregs, a paradigm shift may be required to 





1. Organization, W.H. Obesity and Overweight. 2020  [cited 2021 02/12]; Available 
from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. 
2. Prevention, C.f.D.C.a. Prevalence of Overweight, Obesity, and Severe Obesity 
Among Children and Adolescents Aged 2–19 Years: United States, 1963–1965 
Through 2017–2018. 2018  [cited 2021 02/12]; Available from: 
https://www.cdc.gov/nchs/data/hestat/obesity-child-17-18/obesity-child.htm. 
3. Prevention, C.f.D.C.a. NCHS Data Brief. 2020  [cited 2021 02/12]; Available from: 
https://www.cdc.gov/nchs/data/databriefs/db360_tables-508.pdf#page=4. 
4. Prevention, C.f.D.C.a. Obesity and Overweight. 2018  [cited 2021 02/12]; Available 
from: https://www.cdc.gov/nchs/fastats/obesity-overweight.htm. 
5. Cawley, J., et al., Direct medical costs of obesity in the United States and the most 
populous states. J Manag Care Spec Pharm, 2021: p. 1-13. 
6. Goettler, A., A. Grosse, and D. Sonntag, Productivity loss due to overweight and 
obesity: a systematic review of indirect costs. BMJ Open, 2017. 7(10): p. e014632. 
7. Spieker, E.A. and N. Pyzocha, Economic Impact of Obesity. Prim Care, 2016. 
43(1): p. 83-95, viii-ix. 
8. González-Muniesa, P., et al., Obesity. Nat Rev Dis Primers, 2017. 3: p. 17034. 
9. Maliszewska, K. and A. Kretowski, Brown Adipose Tissue and Its Role in Insulin 
and Glucose Homeostasis. Int J Mol Sci, 2021. 22(4). 
10. Drucker, D.J., Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end 
of the beginning. Cell Metab, 2021. 
11. Becker, M., M.K. Levings, and C. Daniel, Adipose-tissue regulatory T cells: Critical 
players in adipose-immune crosstalk. Eur J Immunol, 2017. 47(11): p. 1867-1874. 
12. Zatterale, F., et al., Chronic Adipose Tissue Inflammation Linking Obesity to Insulin 
Resistance and Type 2 Diabetes. Front Physiol, 2019. 10: p. 1607. 
13. AlZaim, I., et al., Adipose Tissue Immunomodulation: A Novel Therapeutic 
Approach in Cardiovascular and Metabolic Diseases. Front Cardiovasc Med, 
2020. 7: p. 602088. 
14. Asif, S., et al., Understanding Dietary Intervention-Mediated Epigenetic 
Modifications in Metabolic Diseases. Front Genet, 2020. 11: p. 590369. 
 95 
15. Wang, G.X., X.Y. Zhao, and J.D. Lin, The brown fat secretome: metabolic functions 
beyond thermogenesis. Trends Endocrinol Metab, 2015. 26(5): p. 231-7. 
16. Li, Y., Y. Meng, and X. Yu, The Unique Metabolic Characteristics of Bone Marrow 
Adipose Tissue. Front Endocrinol (Lausanne), 2019. 10: p. 69. 
17. Wolf, A.M., et al., Adiponectin induces the anti-inflammatory cytokines IL-10 and 
IL-1RA in human leukocytes. Biochem Biophys Res Commun, 2004. 323(2): p. 
630-5. 
18. Ohashi, K., et al., Adiponectin promotes macrophage polarization toward an anti-
inflammatory phenotype. J Biol Chem, 2010. 285(9): p. 6153-60. 
19. Spallanzani, R.G., et al., Distinct immunocyte-promoting and adipocyte-generating 
stromal components coordinate adipose tissue immune and metabolic tenors. Sci 
Immunol, 2019. 4(35). 
20. Mahlakõiv, T., et al., Stromal cells maintain immune cell homeostasis in adipose 
tissue via production of interleukin-33. Sci Immunol, 2019. 4(35). 
21. Molofsky, A.B., et al., Innate lymphoid type 2 cells sustain visceral adipose tissue 
eosinophils and alternatively activated macrophages. J Exp Med, 2013. 210(3): p. 
535-49. 
22. Wu, D., et al., Eosinophils sustain adipose alternatively activated macrophages 
associated with glucose homeostasis. Science, 2011. 332(6026): p. 243-7. 
23. Feuerer, M., et al., Lean, but not obese, fat is enriched for a unique population of 
regulatory T cells that affect metabolic parameters. Nature medicine, 2009. 15(8): 
p. 930-939. 
24. LaMarche, N.M., et al., Distinct iNKT Cell Populations Use IFNγ or ER Stress-
Induced IL-10 to Control Adipose Tissue Homeostasis. Cell Metab, 2020. 32(2): p. 
243-258.e6. 
25. Saraiva, M., P. Vieira, and A. O'Garra, Biology and therapeutic potential of 
interleukin-10. J Exp Med, 2020. 217(1). 
26. Cinti, S., et al., Adipocyte death defines macrophage localization and function in 
adipose tissue of obese mice and humans. J Lipid Res, 2005. 46(11): p. 2347-55. 
27. Altintas, M.M., et al., Mast cells, macrophages, and crown-like structures 
distinguish subcutaneous from visceral fat in mice. J Lipid Res, 2011. 52(3): p. 
480-8. 
28. Chylikova, J., et al., Macrophages of the subcutaneous and omental fatty tissue in 
obese patients: Immunohistochemical phenotyping of M2 subtypes in relation to 
 96 
type 2 diabetes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2020. 
164(2): p. 133-137. 
29. Suganami, T., J. Nishida, and Y. Ogawa, A paracrine loop between adipocytes 
and macrophages aggravates inflammatory changes: role of free fatty acids and 
tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol, 2005. 25(10): p. 2062-
8. 
30. Bradley, D., et al., Adipose Tissue T Regulatory Cells: Implications for Health and 
Disease. Adv Exp Med Biol, 2021. 1278: p. 125-139. 
31. Zhao, X.Y., et al., The obesity-induced adipokine sST2 exacerbates adipose T(reg) 
and ILC2 depletion and promotes insulin resistance. Sci Adv, 2020. 6(20): p. 
eaay6191. 
32. Ye, J., et al., Hypoxia is a potential risk factor for chronic inflammation and 
adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J 
Physiol Endocrinol Metab, 2007. 293(4): p. E1118-28. 
33. Rausch, M.E., et al., Obesity in C57BL/6J mice is characterized by adipose tissue 
hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond), 2008. 32(3): p. 451-63. 
34. Sung, H.K., et al., Adipose vascular endothelial growth factor regulates metabolic 
homeostasis through angiogenesis. Cell Metab, 2013. 17(1): p. 61-72. 
35. González-Muniesa, P., et al., Effects of Hyperoxia on Oxygen-Related 
Inflammation with a Focus on Obesity. Oxid Med Cell Longev, 2015. 2015: p. 
8957827. 
36. Dowal, L., et al., Intrinsic Properties of Brown and White Adipocytes Have 
Differential Effects on Macrophage Inflammatory Responses. Mediators Inflamm, 
2017. 2017: p. 9067049. 
37. Shankar, K., et al., Role of brown adipose tissue in modulating adipose tissue 
inflammation and insulin resistance in high-fat diet fed mice. Eur J Pharmacol, 
2019. 854: p. 354-364. 
38. London, A., et al., The Role of Hepatic Fat Accumulation in Glucose and Insulin 
Homeostasis-Dysregulation by the Liver. J Clin Med, 2021. 10(3). 
39. Samuel, V.T. and G.I. Shulman, Mechanisms for insulin resistance: common 
threads and missing links. Cell, 2012. 148(5): p. 852-71. 
40. Browning, J.D. and J.D. Horton, Molecular mediators of hepatic steatosis and liver 
injury. J Clin Invest, 2004. 114(2): p. 147-52. 
41. Oh, Y.S., et al., Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During 
Development of Type 2 Diabetes. Front Endocrinol (Lausanne), 2018. 9: p. 384. 
 97 
42. Fabbrini, E. and F. Magkos, Hepatic Steatosis as a Marker of Metabolic 
Dysfunction. Nutrients, 2015. 7(6): p. 4995-5019. 
43. Cypess, A.M., et al., Identification and importance of brown adipose tissue in adult 
humans. N Engl J Med, 2009. 360(15): p. 1509-17. 
44. White, J.D., R.S. Dewal, and K.I. Stanford, The beneficial effects of brown adipose 
tissue transplantation. Mol Aspects Med, 2019. 68: p. 74-81. 
45. Damal Villivalam, S., et al., TET1 is a beige adipocyte-selective epigenetic 
suppressor of thermogenesis. Nat Commun, 2020. 11(1): p. 4313. 
46. Guo, X., et al., cAMP-MicroRNA-203-IFNγ network regulates subcutaneous white 
fat browning and glucose tolerance. Mol Metab, 2019. 28: p. 36-47. 
47. Auffret, J., et al., Beige differentiation of adipose depots in mice lacking prolactin 
receptor protects against high-fat-diet-induced obesity. Faseb j, 2012. 26(9): p. 
3728-37. 
48. Stine, R.R., et al., EBF2 promotes the recruitment of beige adipocytes in white 
adipose tissue. Mol Metab, 2016. 5(1): p. 57-65. 
49. McGregor, R.A., et al., Time-course microarrays reveal modulation of 
developmental, lipid metabolism and immune gene networks in intrascapular 
brown adipose tissue during the development of diet-induced obesity. Int J Obes 
(Lond), 2013. 37(12): p. 1524-31. 
50. Alcalá, M., et al., Increased inflammation, oxidative stress and mitochondrial 
respiration in brown adipose tissue from obese mice. Sci Rep, 2017. 7(1): p. 
16082. 
51. Peterson, K.R., D.K. Flaherty, and A.H. Hasty, Obesity Alters B Cell and 
Macrophage Populations in Brown Adipose Tissue. Obesity (Silver Spring), 2017. 
25(11): p. 1881-1884. 
52. Lettieri-Barbato, D. and K. Aquilano, Aging and Immunometabolic Adaptations to 
Thermogenesis. Ageing Res Rev, 2020. 63: p. 101143. 
53. Sakamoto, T., et al., Macrophage infiltration into obese adipose tissues 
suppresses the induction of UCP1 level in mice. Am J Physiol Endocrinol Metab, 
2016. 310(8): p. E676-e687. 
54. Wolf, Y., et al., Brown-adipose-tissue macrophages control tissue innervation and 
homeostatic energy expenditure. Nat Immunol, 2017. 18(6): p. 665-674. 
55. Elieh Ali Komi, D., F. Shafaghat, and M. Christian, Crosstalk Between Mast Cells 
and Adipocytes in Physiologic and Pathologic Conditions. Clin Rev Allergy 
Immunol, 2020. 58(3): p. 388-400. 
 98 
56. Ding, X., et al., IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic 
tone and suppressed by obesity. J Endocrinol, 2016. 231(1): p. 35-48. 
57. Hui, X., et al., Adiponectin Enhances Cold-Induced Browning of Subcutaneous 
Adipose Tissue via Promoting M2 Macrophage Proliferation. Cell Metab, 2015. 
22(2): p. 279-90. 
58. Qiu, Y., et al., Eosinophils and type 2 cytokine signaling in macrophages 
orchestrate development of functional beige fat. Cell, 2014. 157(6): p. 1292-1308. 
59. Nguyen, K.D., et al., Alternatively activated macrophages produce catecholamines 
to sustain adaptive thermogenesis. Nature, 2011. 480(7375): p. 104-8. 
60. Lee, M.W., et al., Activated type 2 innate lymphoid cells regulate beige fat 
biogenesis. Cell, 2015. 160(1-2): p. 74-87. 
61. Brestoff, J.R., et al., Group 2 innate lymphoid cells promote beiging of white 
adipose tissue and limit obesity. Nature, 2015. 519(7542): p. 242-6. 
62. Finlin, B.S., et al., Mast Cells Promote Seasonal White Adipose Beiging in 
Humans. Diabetes, 2017. 66(5): p. 1237-1246. 
63. Zhang, X., et al., Functional Inactivation of Mast Cells Enhances Subcutaneous 
Adipose Tissue Browning in Mice. Cell Rep, 2019. 28(3): p. 792-803.e4. 
64. Yabut, J.M., et al., Genetic deletion of mast cell serotonin synthesis prevents the 
development of obesity and insulin resistance. Nat Commun, 2020. 11(1): p. 463. 
65. Wang, G.X., et al., The brown fat-enriched secreted factor Nrg4 preserves 
metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med, 2014. 
20(12): p. 1436-1443. 
66. Potthoff, M.J., et al., FGF21 induces PGC-1alpha and regulates carbohydrate and 
fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci 
U S A, 2009. 106(26): p. 10853-8. 
67. Chartoumpekis, D.V., et al., Brown adipose tissue responds to cold and adrenergic 
stimulation by induction of FGF21. Mol Med, 2011. 17(7-8): p. 736-40. 
68. Burýsek, L. and J. Houstek, beta-Adrenergic stimulation of interleukin-1alpha and 
interleukin-6 expression in mouse brown adipocytes. FEBS Lett, 1997. 411(1): p. 
83-6. 
69. Ellingsgaard, H., et al., Interleukin-6 enhances insulin secretion by increasing 
glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med, 2011. 
17(11): p. 1481-9. 
 99 
70. Kurauti, M.A., et al., Interleukin-6 increases the expression and activity of insulin-
degrading enzyme. Sci Rep, 2017. 7: p. 46750. 
71. Weisberg, S.P., et al., Obesity is associated with macrophage accumulation in 
adipose tissue. J Clin Invest, 2003. 112(12): p. 1796-808. 
72. Chung, K.J., et al., A self-sustained loop of inflammation-driven inhibition of beige 
adipogenesis in obesity. Nat Immunol, 2017. 18(6): p. 654-664. 
73. Goto, T., et al., Proinflammatory cytokine interleukin-1β suppresses cold-induced 
thermogenesis in adipocytes. Cytokine, 2016. 77: p. 107-14. 
74. Okla, M., et al., Inhibitory Effects of Toll-Like Receptor 4, NLRP3 Inflammasome, 
and Interleukin-1β on White Adipocyte Browning. Inflammation, 2018. 41(2): p. 
626-642. 
75. Weinstock, A., et al., Single-Cell RNA Sequencing of Visceral Adipose Tissue 
Leukocytes Reveals that Caloric Restriction Following Obesity Promotes the 
Accumulation of a Distinct Macrophage Population with Features of Phagocytic 
Cells. Immunometabolism, 2019. 1. 
76. Pacella, I. and S. Piconese, Immunometabolic Checkpoints of Treg Dynamics: 
Adaptation to Microenvironmental Opportunities and Challenges. Front Immunol, 
2019. 10: p. 1889. 
77. Mancuso, P. and B. Bouchard, The Impact of Aging on Adipose Function and 
Adipokine Synthesis. Front Endocrinol (Lausanne), 2019. 10: p. 137. 
78. Blaszczak, A.M., et al., Obesogenic Memory Maintains Adipose Tissue 
Inflammation and Insulin Resistance. Immunometabolism, 2020. 2(3). 
79. Cipolletta, D., et al., Appearance and disappearance of the mRNA signature 
characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARγ effects. 
Proc Natl Acad Sci U S A, 2015. 112(2): p. 482-7. 
80. Vasanthakumar, A., et al., Sex-specific adipose tissue imprinting of regulatory T 
cells. Nature, 2020. 579(7800): p. 581-585. 
81. Ishikawa, A., et al., Estrogen regulates sex-specific localization of regulatory T 
cells in adipose tissue of obese female mice. PLoS One, 2020. 15(4): p. e0230885. 
82. Medrikova, D., et al., Brown adipose tissue harbors a distinct sub-population of 
regulatory T cells. PLoS One, 2015. 10(2): p. e0118534. 
83. Lira, F.S., et al., Both adiponectin and interleukin-10 inhibit LPS-induced activation 
of the NF-κB pathway in 3T3-L1 adipocytes. Cytokine, 2012. 57(1): p. 98-106. 
 100 
84. Morris, D.L., et al., Adipose tissue macrophages function as antigen-presenting 
cells and regulate adipose tissue CD4+ T cells in mice. Diabetes, 2013. 62(8): p. 
2762-72. 
85. Cipolletta, D., et al., PPAR-gamma is a major driver of the accumulation and 
phenotype of adipose tissue Treg cells. Nature, 2012. 486(7404): p. 549-53. 
86. Ip, W.K.E., et al., Anti-inflammatory effect of IL-10 mediated by metabolic 
reprogramming of macrophages. Science, 2017. 356(6337): p. 513-519. 
87. Tiemessen, M.M., et al., CD4+CD25+Foxp3+ regulatory T cells induce alternative 
activation of human monocytes/macrophages. Proc Natl Acad Sci U S A, 2007. 
104(49): p. 19446-51. 
88. Liu, X., et al., Tim-3 Regulates Tregs' Ability to Resolve the Inflammation and 
Proliferation of Acute Lung Injury by Modulating Macrophages Polarization. Shock, 
2018. 50(4): p. 455-464. 
89. Ilan, Y., et al., Induction of regulatory T cells decreases adipose inflammation and 
alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A, 2010. 
107(21): p. 9765-70. 
90. Priceman, S.J., et al., Regulation of adipose tissue T cell subsets by Stat3 is crucial 
for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A, 2013. 
110(32): p. 13079-84. 
91. Han, J.M., et al., IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose 
Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation 
and Insulin Resistance. J Immunol, 2015. 194(10): p. 4777-83. 
92. Vasanthakumar, A., et al., The transcriptional regulators IRF4, BATF and IL-33 
orchestrate development and maintenance of adipose tissue-resident regulatory T 
cells. Nat Immunol, 2015. 16(3): p. 276-85. 
93. Bapat, S.P., et al., Depletion of fat-resident Treg cells prevents age-associated 
insulin resistance. Nature, 2015. 528(7580): p. 137-41. 
94. Kälin, S., et al., A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue 
Function. Cell Metab, 2017. 26(3): p. 475-492.e7. 
95. Becker, M., et al., Short-term cold exposure supports human Treg induction in vivo. 
Mol Metab, 2019. 28: p. 73-82. 
96. Kolodin, D., et al., Antigen- and cytokine-driven accumulation of regulatory T cells 
in visceral adipose tissue of lean mice. Cell Metab, 2015. 21(4): p. 543-57. 
97. DiSpirito, J.R., et al., Molecular diversification of regulatory T cells in nonlymphoid 
tissues. Sci Immunol, 2018. 3(27). 
 101 
98. Cipolletta, D., et al., Appearance and disappearance of the mRNA signature 
characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARgamma 
effects. Proc Natl Acad Sci U S A, 2015. 112(2): p. 482-7. 
99. Lynch, L., et al., Regulatory iNKT cells lack expression of the transcription factor 
PLZF and control the homeostasis of T(reg) cells and macrophages in adipose 
tissue. Nat Immunol, 2015. 16(1): p. 85-95. 
100. Li, C., et al., TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the 
Distinctive Fat-Treg Phenotype. Cell, 2018. 174(2): p. 285-299.e12. 
101. Frias, A.B., Jr., et al., The Transcriptional Regulator Id2 Is Critical for Adipose-
Resident Regulatory T Cell Differentiation, Survival, and Function. J Immunol, 
2019. 203(3): p. 658-664. 
102. Wara, A.K., et al., KLF10 Deficiency in CD4(+) T Cells Triggers Obesity, Insulin 
Resistance, and Fatty Liver. Cell Rep, 2020. 33(13): p. 108550. 
103. Keller, A.D. and T. Maniatis, Identification and characterization of a novel repressor 
of beta-interferon gene expression. Genes Dev, 1991. 5(5): p. 868-79. 
104. Turner, C.A., Jr., D.H. Mack, and M.M. Davis, Blimp-1, a novel zinc finger-
containing protein that can drive the maturation of B lymphocytes into 
immunoglobulin-secreting cells. Cell, 1994. 77(2): p. 297-306. 
105. Crotty, S., R.J. Johnston, and S.P. Schoenberger, Effectors and memories: Bcl-6 
and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol, 2010. 11(2): p. 
114-20. 
106. Kim, S.J., Immunological function of Blimp-1 in dendritic cells and relevance to 
autoimmune diseases. Immunol Res, 2015. 63(1-3): p. 113-20. 
107. Chang, D.H., C. Angelin-Duclos, and K. Calame, BLIMP-1: trigger for 
differentiation of myeloid lineage. Nat Immunol, 2000. 1(2): p. 169-76. 
108. Martins, G.A., et al., Transcriptional repressor Blimp-1 regulates T cell 
homeostasis and function. Nat Immunol, 2006. 7(5): p. 457-65. 
109. Kallies, A., et al., Transcriptional repressor Blimp-1 is essential for T cell 
homeostasis and self-tolerance. Nat Immunol, 2006. 7(5): p. 466-74. 
110. Kallies, A., et al., Blimp-1 transcription factor is required for the differentiation of 
effector CD8(+) T cells and memory responses. Immunity, 2009. 31(2): p. 283-95. 
111. Rutishauser, R.L., et al., Transcriptional repressor Blimp-1 promotes CD8(+) T cell 
terminal differentiation and represses the acquisition of central memory T cell 
properties. Immunity, 2009. 31(2): p. 296-308. 
 102 
112. Ji, Y., et al., Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the 
formation of memory CD8+ T cells. Nat Immunol, 2011. 12(12): p. 1230-7. 
113. Cretney, E., et al., The transcription factors Blimp-1 and IRF4 jointly control the 
differentiation and function of effector regulatory T cells. Nat Immunol, 2011. 12(4): 
p. 304-11. 
114. Sciammas, R., et al., Graded expression of interferon regulatory factor-4 
coordinates isotype switching with plasma cell differentiation. Immunity, 2006. 
25(2): p. 225-36. 
115. Kwon, H., et al., Analysis of interleukin-21-induced Prdm1 gene regulation reveals 
functional cooperation of STAT3 and IRF4 transcription factors. Immunity, 2009. 
31(6): p. 941-52. 
116. Bankoti, R., et al., Differential regulation of Effector and Regulatory T cell function 
by Blimp1. Sci Rep, 2017. 7(1): p. 12078. 
117. Vasanthakumar, A., et al., The TNF Receptor Superfamily-NF-κB Axis Is Critical 
to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues. 
Cell Rep, 2017. 20(12): p. 2906-2920. 
118. Cretney, E., et al., Characterization of Blimp-1 function in effector regulatory T 
cells. J Autoimmun, 2018. 91: p. 73-82. 
119. Ogawa, C., et al., Blimp-1 Functions as a Molecular Switch to Prevent 
Inflammatory Activity in Foxp3(+)RORγt(+) Regulatory T Cells. Cell Rep, 2018. 
25(1): p. 19-28.e5. 
120. Garg, G., et al., Blimp1 Prevents Methylation of Foxp3 and Loss of Regulatory T 
Cell Identity at Sites of Inflammation. Cell Rep, 2019. 26(7): p. 1854-1868.e5. 
121. Zhou, X., et al., Instability of the transcription factor Foxp3 leads to the generation 
of pathogenic memory T cells in vivo. Nat Immunol, 2009. 10(9): p. 1000-7. 
122. Floess, S., et al., Epigenetic control of the foxp3 locus in regulatory T cells. PLoS 
Biol, 2007. 5(2): p. e38. 
123. Wan, Y.Y. and R.A. Flavell, Identifying Foxp3-expressing suppressor T cells with 
a bicistronic reporter. Proc Natl Acad Sci U S A, 2005. 102(14): p. 5126-31. 
124. Shapiro-Shelef, M., et al., Blimp-1 is required for the formation of immunoglobulin 
secreting plasma cells and pre-plasma memory B cells. Immunity, 2003. 19(4): p. 
607-20. 
125. Rubtsov, Y.P., et al., Regulatory T cell-derived interleukin-10 limits inflammation 
at environmental interfaces. Immunity, 2008. 28(4): p. 546-58. 
 103 
126. Mooli, R.G.R., et al., Sustained mitochondrial biogenesis is essential to maintain 
caloric restriction-induced beige adipocytes. Metabolism, 2020. 107: p. 154225. 
127. Panduro, M., C. Benoist, and D. Mathis, Tissue Tregs. Annu Rev Immunol, 2016. 
34: p. 609-33. 
128. Deng, T., et al., Adipocyte adaptive immunity mediates diet-induced adipose 
inflammation and insulin resistance by decreasing adipose Treg cells. Nature 
Communications, 2017. 8(1): p. 15725. 
129. Yuan, X., G. Cheng, and T.R. Malek, The importance of regulatory T-cell 
heterogeneity in maintaining self-tolerance. Immunological reviews, 2014. 259(1): 
p. 103-114. 
130. Toomer, K.H., et al., Essential and non-overlapping IL-2Rα-dependent processes 
for thymic development and peripheral homeostasis of regulatory T cells. Nat 
Commun, 2019. 10(1): p. 1037. 
131. Ronchetti, S., et al., Glucocorticoid-induced tumour necrosis factor receptor-
related protein: a key marker of functional regulatory T cells. J Immunol Res, 2015. 
2015: p. 171520. 
132. Onodera, T., et al., Adipose tissue macrophages induce PPARγ-high FOXP3(+) 
regulatory T cells. Scientific reports, 2015. 5: p. 16801-16801. 
133. Rajbhandari, P., et al., Single cell analysis reveals immune cell-adipocyte crosstalk 
regulating the transcription of thermogenic adipocytes. Elife, 2019. 8. 
134. Caspar-Bauguil, S., et al., Adipose tissues as an ancestral immune organ: site-
specific change in obesity. FEBS Lett, 2005. 579(17): p. 3487-92. 
135. Caspar-Bauguil, S., et al., Weight-dependent changes of immune system in 
adipose tissue: importance of leptin. Exp Cell Res, 2006. 312(12): p. 2195-202. 
136. Miller, A.M., et al., Interleukin-33 induces protective effects in adipose tissue 
inflammation during obesity in mice. Circ Res, 2010. 107(5): p. 650-8. 
137. Patel, H., C.C. Kerndt, and A. Bhardwaj, Physiology, Respiratory Quotient, in 
StatPearls. 2020, StatPearls Publishing 
Copyright © 2020, StatPearls Publishing LLC.: Treasure Island (FL). 
138. Kühn, R., et al., Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 
1993. 75(2): p. 263-74. 
139. Chaudhry, A., et al., Interleukin-10 signaling in regulatory T cells is required for 
suppression of Th17 cell-mediated inflammation. Immunity, 2011. 34(4): p. 566-
78. 
 104 
140. Keubler, L.M., et al., A Multihit Model: Colitis Lessons from the Interleukin-10-
deficient Mouse. Inflamm Bowel Dis, 2015. 21(8): p. 1967-75. 
141. Griesenauer, B. and S. Paczesny, The ST2/IL-33 Axis in Immune Cells during 
Inflammatory Diseases. Front Immunol, 2017. 8: p. 475. 
142. Morita, Y., et al., Impact of tissue macrophage proliferation on peripheral and 
systemic insulin resistance in obese mice with diabetes. BMJ Open Diabetes Res 
Care, 2020. 8(1). 
143. Wang, Y., et al., Improvement of obesity-associated disorders by a small-molecule 
drug targeting mitochondria of adipose tissue macrophages. Nat Commun, 2021. 
12(1): p. 102. 
144. Antony, A., et al., Deficiency of Stat1 in CD11c(+) Cells Alters Adipose Tissue 
Inflammation and Improves Metabolic Dysfunctions in Mice Fed High-Fat Diet. 
Diabetes, 2020. 
145. Brestoff, J.R., et al., Intercellular Mitochondria Transfer to Macrophages Regulates 
White Adipose Tissue Homeostasis and Is Impaired in Obesity. Cell Metab, 2020. 
146. Orliaguet, L., et al., Mechanisms of Macrophage Polarization in Insulin Signaling 
and Sensitivity. Front Endocrinol (Lausanne), 2020. 11: p. 62. 
147. Matta, B.M., et al., IL-33 is an unconventional Alarmin that stimulates IL-2 secretion 
by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J Immunol, 
2014. 193(8): p. 4010-20. 
148. Macdougall, C.E., et al., Visceral Adipose Tissue Immune Homeostasis Is 
Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell 
Metab, 2018. 27(3): p. 588-601.e4. 
149. Srikakulapu, P. and C.A. McNamara, B Lymphocytes and Adipose Tissue 
Inflammation. Arterioscler Thromb Vasc Biol, 2020. 40(5): p. 1110-1122. 
150. Sattler, S., et al., IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) 
effectively attenuate mucosal inflammatory responses in the gut. J Autoimmun, 
2014. 50(100): p. 107-22. 
151. Li, Y., et al., Natural Killer Cells: Friend or Foe in Metabolic Diseases? Front 
Immunol, 2021. 12: p. 614429. 
152. Wang, L., et al., Metabolic tissue-resident CD8(+) T cells: A key player in obesity-
related diseases. Obes Rev, 2021. 22(3): p. e13133. 
153. Rajbhandari, P., et al., IL-10 Signaling Remodels Adipose Chromatin Architecture 
to Limit Thermogenesis and Energy Expenditure. Cell, 2018. 172(1-2): p. 218-
233.e17. 
 105 
154. Laakso, M., et al., The Metabolic Syndrome in Men study: a resource for studies 
of metabolic and cardiovascular diseases. J Lipid Res, 2017. 58(3): p. 481-493. 
155. Wu, D., et al., T reg-specific insulin receptor deletion prevents diet-induced and 
age-associated metabolic syndrome. J Exp Med, 2020. 217(8). 
156. He, K., et al., Blimp-1 is essential for allergen-induced asthma and Th2 cell 
development in the lung. J Exp Med, 2020. 217(7). 
157. Ouyang, W. and A. O'Garra, IL-10 Family Cytokines IL-10 and IL-22: from Basic 
Science to Clinical Translation. Immunity, 2019. 50(4): p. 871-891. 
158. Vignali, D.A., L.W. Collison, and C.J. Workman, How regulatory T cells work. Nat 
Rev Immunol, 2008. 8(7): p. 523-32. 
159. Seale, P., et al., Transcriptional control of brown fat determination by PRDM16. 
Cell Metab, 2007. 6(1): p. 38-54. 
160. Wu, J., et al., Beige adipocytes are a distinct type of thermogenic fat cell in mouse 
and human. Cell, 2012. 150(2): p. 366-76. 
161. Bettini, M. and D.A. Vignali, Regulatory T cells and inhibitory cytokines in 
autoimmunity. Curr Opin Immunol, 2009. 21(6): p. 612-8. 
162. Shime, H., et al., Proenkephalin(+) regulatory T cells expanded by ultraviolet B 
exposure maintain skin homeostasis with a healing function. Proc Natl Acad Sci U 
S A, 2020. 117(34): p. 20696-20705. 
163. Ito, M., et al., Brain regulatory T cells suppress astrogliosis and potentiate 
neurological recovery. Nature, 2019. 565(7738): p. 246-250. 
164. Fahlén, L., et al., T cells that cannot respond to TGF-beta escape control by 
CD4(+)CD25(+) regulatory T cells. J Exp Med, 2005. 201(5): p. 737-46. 
165. Wing, J.B., C. Tay, and S. Sakaguchi, Control of Regulatory T Cells by Co-signal 
Molecules. Adv Exp Med Biol, 2019. 1189: p. 179-210. 
166. Maj, T., et al., Oxidative stress controls regulatory T cell apoptosis and suppressor 
activity and PD-L1-blockade resistance in tumor. Nat Immunol, 2017. 18(12): p. 
1332-1341. 
167. Deaglio, S., et al., Adenosine generation catalyzed by CD39 and CD73 expressed 
on regulatory T cells mediates immune suppression. J Exp Med, 2007. 204(6): p. 
1257-65. 
168. Ali, N., et al., Regulatory T Cells in Skin Facilitate Epithelial Stem Cell 
Differentiation. Cell, 2017. 169(6): p. 1119-1129.e11. 
 106 
169. Faustino, L.D., et al., Interleukin-33 activates regulatory T cells to suppress innate 
γδ T cell responses in the lung. Nat Immunol, 2020. 21(11): p. 1371-1383. 
170. Kohlgruber, A.C., et al., γδ T cells producing interleukin-17A regulate adipose 
regulatory T cell homeostasis and thermogenesis. Nat Immunol, 2018. 19(5): p. 
464-474. 
171. Yang, B., et al., Transgenic mice specifically expressing amphiregulin in white 
adipose tissue showed less adipose tissue mass. Genes Cells, 2018. 23(3): p. 
136-145. 
172. Besse-Patin, A., et al., PGC1A regulates the IRS1:IRS2 ratio during fasting to 
influence hepatic metabolism downstream of insulin. Proc Natl Acad Sci U S A, 
2019. 116(10): p. 4285-4290. 
173. Estall, J.L., et al., Sensitivity of lipid metabolism and insulin signaling to genetic 
alterations in hepatic peroxisome proliferator-activated receptor-gamma 
coactivator-1alpha expression. Diabetes, 2009. 58(7): p. 1499-508. 
174. Besse-Patin, A., et al., Estrogen Signals Through Peroxisome Proliferator-
Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated 
With Diet-Induced Fatty Liver Disease. Gastroenterology, 2017. 152(1): p. 243-
256. 
175. Kleiner, S., et al., Development of insulin resistance in mice lacking PGC-1α in 
adipose tissues. Proc Natl Acad Sci U S A, 2012. 109(24): p. 9635-40. 
176. Suo, J., et al., Met-enkephalin improves metabolic syndrome in high fat diet 
challenged mice through promotion of adipose tissue browning. Toxicol Appl 
Pharmacol, 2018. 359: p. 12-23. 
177. Gnad, T., et al., Adenosine activates brown adipose tissue and recruits beige 
adipocytes via A2A receptors. Nature, 2014. 516(7531): p. 395-9. 
178. Shevyrev, D. and V. Tereshchenko, Treg Heterogeneity, Function, and 
Homeostasis. Front Immunol, 2019. 10: p. 3100. 
179. Zhang, Q., et al., LAG3 limits regulatory T cell proliferation and function in 
autoimmune diabetes. Sci Immunol, 2017. 2(9). 
180. Johnston, R.J., et al., Bcl6 and Blimp-1 are reciprocal and antagonistic regulators 
of T follicular helper cell differentiation. Science, 2009. 325(5943): p. 1006-10. 
181. Koh, B., et al., Bcl6 and Blimp1 reciprocally regulate ST2(+) Treg-cell development 
in the context of allergic airway inflammation. J Allergy Clin Immunol, 2020. 146(5): 
p. 1121-1136.e9. 
 107 
182. Pompura, S.L., et al., Oleic acid restores suppressive defects in tissue-resident 
FOXP3 Tregs from patients with multiple sclerosis. J Clin Invest, 2021. 131(2). 
183. Sun, M., et al., Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 
production to maintain intestinal homeostasis. Nat Commun, 2018. 9(1): p. 3555. 
184. Sierra, S., et al., Dietary fish oil n-3 fatty acids increase regulatory cytokine 
production and exert anti-inflammatory effects in two murine models of 
inflammation. Lipids, 2006. 41(12): p. 1115-25. 
185. Ly, L.H., et al., Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T 
cell function in interleukin (IL)-10(-/-) mice. Clin Exp Immunol, 2005. 139(2): p. 202-
9. 
186. Singh, N., et al., Activation of Gpr109a, receptor for niacin and the commensal 
metabolite butyrate, suppresses colonic inflammation and carcinogenesis. 
Immunity, 2014. 40(1): p. 128-39. 
187. Field, A.E., et al., Dietary fat and weight gain among women in the Nurses' Health 
Study. Obesity (Silver Spring), 2007. 15(4): p. 967-76. 
188. Raatz, S.K., et al., Relationship of the Reported Intakes of Fat and Fatty Acids to 
Body Weight in US Adults. Nutrients, 2017. 9(5). 
189. Liu, H., et al., Butyrate: A Double-Edged Sword for Health? Adv Nutr, 2018. 9(1): 
p. 21-29. 
190. Palomer, X., et al., Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in 
Type 2 Diabetes Mellitus. Trends Endocrinol Metab, 2018. 29(3): p. 178-190. 
191. Lang, P., et al., Effects of different diets used in diet-induced obesity models on 
insulin resistance and vascular dysfunction in C57BL/6 mice. Sci Rep, 2019. 9(1): 
p. 19556. 
192. Hasegawa, Y., et al., Long-term effects of western diet consumption in male and 
female mice. Sci Rep, 2020. 10(1): p. 14686. 
193. Fabrizi, M., et al., IL-21 is a major negative regulator of IRF4-dependent lipolysis 
affecting Tregs in adipose tissue and systemic insulin sensitivity. Diabetes, 2014. 
63(6): p. 2086-96. 
194. Han, J.M., et al., Insulin inhibits IL-10-mediated regulatory T cell function: 
implications for obesity. J Immunol, 2014. 192(2): p. 623-9. 
195. Thomou, T., et al., Adipose-derived circulating miRNAs regulate gene expression 
in other tissues. Nature, 2017. 542(7642): p. 450-455. 
 108 
196. Heyn, G.S., L.H. Corrêa, and K.G. Magalhães, The Impact of Adipose Tissue-
Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. Front Endocrinol 
(Lausanne), 2020. 11: p. 563816. 
197. Chiou, S.H., et al., BLIMP1 Induces Transient Metastatic Heterogeneity in 
Pancreatic Cancer. Cancer Discov, 2017. 7(10): p. 1184-1199. 
198. Huda, M.N., M. Kim, and B.J. Bennett, Modulating the Microbiota as a Therapeutic 
Intervention for Type 2 Diabetes. Front Endocrinol (Lausanne), 2021. 12: p. 
632335. 
199. Makita, N., et al., IL-10 enhances the phenotype of M2 macrophages induced by 
IL-4 and confers the ability to increase eosinophil migration. Int Immunol, 2015. 
27(3): p. 131-41. 
200. Hill, A.A., W. Reid Bolus, and A.H. Hasty, A decade of progress in adipose tissue 
macrophage biology. Immunol Rev, 2014. 262(1): p. 134-52. 
201. Poholek, A.C., et al., IL-10 induces a STAT3-dependent autoregulatory loop in 
T(H)2 cells that promotes Blimp-1 restriction of cell expansion via antagonism of 
STAT5 target genes. Sci Immunol, 2016. 1(5). 
202. Howard, E., et al., IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates 
cellular metabolism, and ameliorates airway hyperreactivity. J Allergy Clin 
Immunol, 2021. 147(4): p. 1281-1295.e5. 
203. Bando, J.K., et al., ILC2s are the predominant source of intestinal ILC-derived IL-
10. J Exp Med, 2020. 217(2). 
204. Nishimura, S., et al., CD8+ effector T cells contribute to macrophage recruitment 
and adipose tissue inflammation in obesity. Nat Med, 2009. 15(8): p. 914-20. 
205. Moysidou, M., et al., CD8+ T cells in beige adipogenesis and energy homeostasis. 
JCI Insight, 2018. 3(5). 
206. Bedke, T., et al., Title: IL-10-producing T cells and their dual functions. Semin 
Immunol, 2019. 44: p. 101335. 
207. Lynch, L., et al., Adipose tissue invariant NKT cells protect against diet-induced 
obesity and metabolic disorder through regulatory cytokine production. Immunity, 
2012. 37(3): p. 574-87. 
208. Sag, D., et al., IL-10-producing NKT10 cells are a distinct regulatory invariant NKT 
cell subset. J Clin Invest, 2014. 124(9): p. 3725-40. 
209. Lynch, L., et al., iNKT Cells Induce FGF21 for Thermogenesis and Are Required 
for Maximal Weight Loss in GLP1 Therapy. Cell Metab, 2016. 24(3): p. 510-519. 
 109 
210. Nishimura, S., et al., Adipose Natural Regulatory B Cells Negatively Control 
Adipose Tissue Inflammation. Cell Metab, 2013. 18(5): p. 759-766. 
211. Rau, M., et al., Progression from Nonalcoholic Fatty Liver to Nonalcoholic 
Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an 
Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the 
Liver. J Immunol, 2016. 196(1): p. 97-105. 
212. He, B., et al., The imbalance of Th17/Treg cells is involved in the progression of 
nonalcoholic fatty liver disease in mice. BMC Immunol, 2017. 18(1): p. 33. 
213. Kornete, M., E. Sgouroudis, and C.A. Piccirillo, ICOS-dependent homeostasis and 
function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J 
Immunol, 2012. 188(3): p. 1064-74. 
214. Tan, T.G., D. Mathis, and C. Benoist, Singular role for T-BET+CXCR3+ regulatory 
T cells in protection from autoimmune diabetes. Proc Natl Acad Sci U S A, 2016. 
113(49): p. 14103-14108. 
215. Khan, I.M., et al., Intermuscular and perimuscular fat expansion in obesity 
correlates with skeletal muscle T cell and macrophage infiltration and insulin 
resistance. Int J Obes (Lond), 2015. 39(11): p. 1607-18. 
216. Shabani, M., et al., Resveratrol alleviates obesity-induced skeletal muscle 
inflammation via decreasing M1 macrophage polarization and increasing the 
regulatory T cell population. Sci Rep, 2020. 10(1): p. 3791. 
217. Suzuki, T., et al., Interleukin-6 enhances glucose-stimulated insulin secretion from 
pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. 
Diabetes, 2011. 60(2): p. 537-47. 
218. Hong, E.G., et al., Interleukin-10 prevents diet-induced insulin resistance by 
attenuating macrophage and cytokine response in skeletal muscle. Diabetes, 
2009. 58(11): p. 2525-35. 
219. Symonds, M.E., et al., Adipose tissue growth and development: the modulating 
role of ambient temperature. J Endocrinol, 2021. 248(1): p. R19-r28. 
 
